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Chapter 1.  Introduction, part 1
Oligomenorrhoea, generally defined as a mean cycle length >6 weeks, and
amenorrhoea, less than one menstrual period in 6 months, are frequent causes
of subfertility or infertility, since they are present in about 20% of the couples
that attend a fertility clinic (Hull e t  a l ., 1985). Regular cycles, especially when
they are accompanied by symptons such as premenstrual breast-swelling or
dysmenorrhoea, are usually regarded as ovulatory. Progesterone production
in the second half of the cycle further indicates the occurrence of ovulation.
Progesterone may be demonstrated qualitatively by recording a basal body
temperature chart, as well as quantitatively by measuring progesterone con-
centrations in blood or saliva. However, since ultrasound techniques have
been developed by which the growth of ovarian follicles, and the occurrence
of ovulation can be visualized, several subtle disorders have been described in
women with regular menstrual cycles (Coutts e t  a l ., 1982; Polan e t  a l ., 1982;
Kerin e t  a l ., 1983; Daly e t  a l ., 1985; Hamilton e t  a l ., 1985; 1987; Lewinthal,
1986; Eissa e t  a l ., 1987; Petsos, 1987; Van Zonneveld e t  a l ., 1994; Rodin e t  a l .,
1994). Ovulation may either not occur at all (luteinized unruptured follicle,
LUF) or may occur too early. (Polan e t  a l ., 1982; Eissa e t  a l ., 1987). In LUF
cycles a normal increase of serum estradiol concentrations is observed as well
as a normal increase in diameter of the dominant follicle. However, in spite of
the fact that progesterone levels rise to (almost) normal levels during the luteal
phase, the follicle does not rupture. Ovulation more than 48 hours after the
LH peak value is considered to occur too late (World Health Organization,
1980; Eissa e t  a l., 1986; OHerlihy e t  a l ., 1980; Zegers-Hochschild e t  a l ., 1984,
Rodin e t  a l ., 1994). Much attention has been paid to a disorder called luteal
phase defect (LPD), defined as an insufficient development of the endometrium
to permit a pre-embryo to implant. LPD is assumed to be caused by a shortage
of progesterone production by the corpus luteum or an inadequate response
of the endometrium to normal progesterone levels. However, whether LPD
really is a cause of subfertility has not been established (Li and Cooke, 1991).
Little is known about the course of LH serum levels during the menstrual
cycle. Elevated levels during the follicular phase have been found in patients
who had recurrent miscarriages compared to controls (Regan e t  a l., 1990), but
a beneficial effect of strategies by which LH levels can be lowered, has not
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been demonstrated (Balen e t  a l ., 1993). The pattern of the LH surge has been
related to the probability of conception in spontaneous cycles in which in-
semination was applied because of cervical hostility. The pregnancy rate was
significantly higher in cycles with an LH surge of 2 days compared to cycles
with a surge of 1 day. Whether a suboptimal LH surge results from a less
optimal follicular phase, or from an insufficient positive feedback system, is
unknown (Cohlen e t  a l ., 1993).
In elderly but still regularly cycling women, the first endocrine change by
aging is a monotropic rise of early follicular FSH (Sherman e t  a l ., 1976; Musey
e t  a l ., 1987; Lee e t  a l ., 1988; Fitzgerald e t  a l ., 1994; Ahmed Ebbiari e t  a l ., 1994;
Klein e t  a l ., 1996; Reyes e t  a l ., 1997). Shortening of the follicular phase of the
cycle is another characteristic of reproductive aging (Treloar e t  a l ., 1967; Lenton
e t  a l ., 1984; Klein and Soules, 1998). Elevated early follicular FSH levels have
been found in regularly cycling women with unexplained subfertility (Ahmed
Ebbiari e t  a l ., 1994; Leach e t  a l ., 1997). The authors postulate that this may
represent a very early sign of follicle depletion. Elevated FSH levels have also
been described in premenopausal mothers of hereditary dizygotic twins. This
was attributed to an altered responsiveness of the hypothalamus and/or pitui-
tary to ovarian factors, not to age (Lambalk e t  a l ., 1998).  Whether disorders of
follicle growth or ovulation occur more often in aging women who still have
regular cycles, is unknown.
In this chapter we will first describe characteristics of the normal menstrual
cycle. Subsequently, we will summarize the present knowledge on subtle cy-
cle disorders and their relation with subfertility. In Chapter 2, we will focus on
the age-related decline of fertility.
The normal menstrual cycle
The three major organs involved in the regulation of reproductive function are
the hypothalamus, the pituitary gland (the so-called central system) and the
ovaries. For many years it has been thought that the cyclical pattern of the
menstrual cycle is governed by the central system via the gonadotropins that
stimulate the ovarian follicles. However, it has become clear that the follicle
system of the ovary provides the key signals for the ovulation, the develop-
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ment of the corpus luteum, and the timing of menstruations (Nakai e t  a l .,
1978; Knobil, 1980).
The central system
Within the arcuate nucleus of the hypothalamus, neuro-endocrine cells pro-
duce the gonadotropin-releasing hormone (GnRH), a decapeptide. These neu-
rons are influenced by neurotransmitters from other parts of the brain, and
hormones, mainly originating from the ovaries. Gonadotropin-releasing hor-
mone reaches the anterior pituitary through the portal vessels located in the
pituitary stalk, and stimulates the synthesis and release of the glycoproteins
follicle stimulating hormone (FSH) and luteinizing hormone (LH) by the same
gonadotropin-secreting cells, the so-called gonadotrops. Differences in FSH
and LH responses are caused by different feedback effects of ovarian hor-
mones. To produce FSH and LH the gonadotrops require a pulsatile stimula-
tion by GnRH (Knobil, 1980), while constant or excessive GnRH stimulation
causes their desensitization. During the early follicular phase of the menstrual
cycle the pulse interval is about 90’, increasing to about 60’ during the late
follicular phase. In the luteal phase the pulse frequency slows down to an
interval of some hours. FSH and LH consist of two amino-acid chains (a- and
b-subunits) which combine to a heterodimer. Apart from FSH and LH the a-
subunit is present in human chorionic gonadotropin (hCG) and thyroid stimu-
lating hormone (TSH). The b-subunit is unique for each hormone and deter-
mines the specific biologic activity.
The ovary
From 4-6 weeks of gestation the primordial gonads can be identified in human
embryos as ridges, created by the coelomic surface epithelial cells. The germ
cells are thought to migrate from the yolk sac to the gonadal ridges, where
they start to multiplicate. At 16-20 weeks of gestation the ovaries are estimated
to contain 7 million oogonia (Baker, 1963). From about that time a decrease of
the stock of germ cells starts. The oogonia are transformed to oocytes by
entering the prophase of the first meiotic division after which they are arrested
in the last stage of the prophase, and surrounded by one layer of flat
15
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granulosacells, the combination of which is called a primordial follicle. The
oocytes stay in this arrested stage for many years, and only resume meiosis in
the dominant follicle just before ovulation. After birth the loss of  primordial
follicles continues, leaving only about 300,000 of them at the menarche. Meno-
pause occurs when almost the entire stock of fol l ic les is  exhausted.
Regulation of the menstrual cycle
For an understanding of the processes that take place, the menstrual cycle can
be divided into 3 phases: the late-luteal and follicular phase, the peri-ovula-
tory phase and the luteal phase.
The  la t e  lu t ea l  and  ear l y  f o l l i cu la r  phas e
From the store of primordial follicles, some follicles start to grow continuously
by a process of maturation. Such development of resting follicles is considere d
to be a gonadotropin-independent process, although there are indications for
a facilitating effect of FSH (Te Velde e t  a l ., 1998). After several months of
growth a group of follicles emerges that have matured to a stage in which they
can be stimulated by FSH to further growth. From this cohort of small antral
follicles, one follicle will be selected which eventually ovulates , the so-called
leading or dominant follicle. The selection of the dominant follicle from the
cohort of small antral follicles , during the late luteal and early follicular phase,
lasts not more than 10 days (Gougeon, 1996). As a consequence of the con-
tinuing maturation of primordial follicles there is always a number of small
antral follicles that can be stimulated to further growth, provided FSH levels
exceed a certain threshold-level during a sufficient period of time, the so-
called FSH window (Brown, 1978; Fauser and Van Heusden, 1997). It is as-
sumed that the most advanced and most sensitive healthy follicle is the one
that will become the dominant follicle (Glasier e t  a l ., 1989). The other follicles
of the same cohort are destined to undergo atresia by a process of programmed
cell death.
A late luteal and early follicular rise in FSH blood levels is the result of lysis of
the corpus luteum at the end of its life-span. This lysis causes a declining
secretion of steroid hormones (E
2
 and progesterone) and protein substances
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(e.g. inhibin A), resulting in a diminished negative feedback upon the central
system. (Nippold e t  a l ., 1989; Le Nestour e t  a l ., 1993; Danforth e t  a l ., 1998;
Welt e t  a l ., 1999; Santoro  e t  a l ., 1999). A subsequent increase in GnRH pulse
frequency is followed by an increase of FSH and -to a lesser degree- of LH
(Hall e t  a l ., 1992). Under the influence of FSH the granulosacells of the preantral
follicles are able to aromatize androgen precursors into estrogens. Androgens
are synthesized in the theca cells by stimulation of LH, and reach the
granulosacells by diffusion through the basement membrane (the so-called
two-cell, two-gonadotropin system) (Kobayashi e t  a l ., 1990). In cooperation
with estrogens, FSH also stimulates an increase in the number of its own
receptors (LaPolt e t  a l ., 1992), and the proliferation of granulosa cells (Yong e t
a l ., 1992).
As the follicles develop, follicular fluid accumulates between the granulosa
cells forming a a space, the antrum. The granulosa cells that surround the
oocyte differentiate into cells called cumulus cells. Increasing production of
estrogens and probably also inhibin B result in decreasing FSH levels by nega-
tive feedback (Glasier e t  a l ., 1989; Van Santbrink e t  a l ., 1995; Groome e t  a l .,
1996). The dominant follicle is thought to survive by its enhanced sensitivity
for FSH due to its superior amount of FSH receptors, while less developed
follicles do not withstand the fall in FSH (Glasier e t  a l ., 1989; Fauser and van
Heusden, 1997) .
The  p e r i - o vu la t o r y  phas e
In concert with estradiol FSH induces the development of LH receptors on
granulosa cells of large follicles. (Kessel e t  a l ., 1985; Hillier e t  a l ., 1985). As
estradiol rises, a positive feedback mechanism towards the central system is
activated. As a result, a transition from suppression to stimulation of LH oc-
curs, and its massive release, the so-called LH-surge (Hoff e t  a l ., 1983). An
untimely start of the LH surge is thought to be prevented by a gonadotropin
surge-inhibiting factor (GnSIF), secreted by the ovary (De Koning, 1995).  LH
induces luteinization of the granulosa cells, which start the production of
progesterone. The LH surge is considered as the most reliable predictor of
ovulation, which occurs 34-36 h after its onset and 10-12 h after its peak level
(Hoff e t  a l ., 1983). The LH surge stimulates several events: 1. The resumption
17
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of the first meiotic division, 2. Luteinization of granulosa cells, 3. Expansion of
the cumulus cells, which enables the oocyte to be released at ovulation, 4.
Synthesis of substances including prostaglandins and proteolytic enzymes, that
are necessary to weaken the wall of the follicle and enable its rupture .
The  lu t ea l  phas e
After ovulation, luteinization continues. Granulosa cells enlarge and accumu-
late a yellow pigment, lutein. The so-called corpus luteum is formed. Theca
cells also luteinize and become part of the corpus luteum. An extensive angio-
genesis takes place, induced by LH and growth factors. Large amounts of
progesterone and E
2
 are produced, reaching a maximum at about 8 days after
ovulation. For its normal lifespan of about 14 days the corpus luteum requires
(small amounts of) LH (Vande Wiele e t  a l ., 1970). During the luteal phase
gonadotropin levels are low due to negative feedback by the combined ac-
tions of E
2
, progesterone and also inhibin A. Luteolysis starts 9-11 days after
ovulation, but the mechanisms controlling this process are not yet clear. The
life-span of the corpus luteum can only be prolonged by hCG, that is pro-
duced by a developing pregnancy. Otherwise, declining E
2
 and progesterone
result in shedding of the endometrium and menstruation.
Criteria to consider a cycle as normal
The development of a dominant follicle determines the length of the follicular
phase, while the length of the luteal phase remains more or less stable. The
length of the follicular phase and thus the length of the menstrual cycle short-
ens gradually from age 30 until about 45. Some years before menopause the
mean cycle length increases again due to the presence of anovulatory cycles
and irregular bleeding (Treloar, 1967).
Although much is known about hormonal patterns and follicle development
in the normal menstrual cycle, it is difficult to define cycle abnormalities un-
less there is no follicle growth at all or no ovulation. In some studies criteria
for normality have been defined (Van Zonneveld e t  a l ., 1994). It has been
suggested that conception cycles are the gold standard for normality, how-
ever, reports on large series are lacking. In addition, also in such ideal cycles,
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hormone levels and sonographic findings vary greatly. For example, ovulation
of a follicle of 13 mm may result in a normal pregnancy (Van Zonneveld e t  a l .,
1994). Moreover, the occurrence of pregnancy is dependent on many female
and male factors and therefore it is likely that, on the one hand, many ideal
cycles never result in a pregnancy, e.g. because of suboptimal timing of inter-
course, whereas, on the other hand, women with suboptimal cycles may con-
ceive, provided all other contributing factors are perfect. The occurrence of
pregnancy is the result of a complex and multifactorial process, and it is well
possible, therefore, that the achievement of clear-cut and generally applicable
criteria of cycle normality is an impossible goal.
Follicular growth has been studied including conception and nonconception
cycles.  Table 1 shows the pre-ovulatory follicle diameters, that have been
found in conception cyles; in Table 2, follicle diameters before ovulation or
follicle aspiration for in-vitro fertilization (patients with a spontaneous LH
surge) are shown. OHerlihy e t  a l . (1980) found a pre-ovulatory range of mean
follicular diameter of 17-25 mm, and a good correlation between the calcu-
lated volume on the basis of ultrasound, and the volume of aspirated follicular
fluid. Other groups found similar pre-ovulatory follicle diameters. Zegers-
Hochschild e t  a l . (1984) found in 13 spontaneous conception cycles a varia-
tion of 15-23.3 mm (Table 1) with a 95% interval of 18.3-21.0 mm; Eissa e t  a l .
(1986) a range of 18-25 mm in 12 spontaneous conception cycles. From ovu-
lation induction studies it is known, that the diameter is related to their prob-
ability to ovulate. Stanger and Yovitch (1984) found that 80% of follicles larger
than 16 mm at the time of HCG ovulated, in contrast to 27% of follicles of 15-
16 mm in diameter. This was confirmed by Silverberg  e t  a l . (1991) who ob-
served that follicles of 17 mm or larger are more likely to ovulate after HCG
administration than smaller follicles. In their IVF laboratory, Bomsel-Helmreich
et al .  (1987) could not find nuclear maturation in oocytes that were collected
from follicles smaller than 16 mm in diameter. Follicle rupture (Table 3) is
assumed if the follicle has disappeared or markedly decreased in size (Hamil-
ton e t  a l ., 1985; Thomas and Cooke, 1988). Fluid in the pouch of Douglas,
being confirmatory evidence, is not always seen. Eissa e t  a l . (1986) observed a
decrease in diameter of at least 89% in 9 conception cycles, within 48h after
the LH peak value. They consider a decrease in mean follicle diameter of at
least 60% as evidence of ovulation (Eissa e t  a l ., 1987).
19
Introduction, part 1
Table 1. Pre- ovulatory follicle diameters in conception cycles
Author Group characteristics No. of cycles Characteristics
Zegers-Hochschild et
al., 1984
25 multiparous volunteers 13 cycles Follicle diameters 15-23.3 mm (mean 19.65)
Spontaneous cycles in
infertility patients
12 cycles In 1 cycle no follicle visible; in 11 cycles foll. diam. 18-25 mm
(mean 19.4 mm)
Eissa et al., 1986
Ovulation induction cycles
(several methods)
8 cycles Follicles 15.7 - 21.3 mm (mean 17.8 mm) (note: hCG
administered in some cycles)
20 Chapter 1Table 2. Pre-ovulatory follicle diameters, or diameters before follicle aspiration in cycles with a spontaneous LH surge
Author Group characteristics No. of patients and
cycles
Follicle diameters
OHerlihy et al., 1980 IVF cycles 36 patients; 29
spontaneous, 7
stimulated cycles
17-25 mm after the start of the LH surge
Zegers-Hochschild et
al., 1984
Non-conception cycles
in 25 multiparous
volunteers
15 cycles 15.6-25.5 mm (mean 19.1) before ovulation
Eissa 1986 Spontaneous cycles in
infertility patients
12 cycles In 1 cycle no follicle visible
In 11 cycles follicle diameter 18-25 mm (mean 19.4 mm)
21
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Table 3. Definition of ovulation by ultrasound
Author Definition or observation
Zegers-Hochschild et
al., 1984
Observed disappearance of echo-free structure in all of 28 cycles
Hamilton et al., 1985 Disappearance or a decrease in mean follicular diameter
Lewinthal et al., 1986 Disappearance or decrease in size
Thomas and Cooke,
1988
Disappearance or markedly decrease in size
Eissa et al., 1986 At least 60% decrease in diameter
Janssen-Caspers et al.,
1986
At least 5 mm decrease in diameter
Vermesh et al.,1987 Observed disappearance of the dominant follicle in 14 spontaneous cycles in infertility patients
Petsos et al., 1987 Disappearance or collapse within 48h after the LH surge
Check et al., 1990 At least 5 mm decrease in diameter, 3 days after hCG in HMG-stimulated cycles
Rodin et al., 1994 Observed >50% shrinkage or disappearance within 48h after the LH surge
Leach et al., 1997 Follicular collapse, >15% decrease in follicular size, and/or the presence of increased echogenicity within the follicle.
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However, good imaging of the ovaries is a prerequisite. Eissa e t  a l . (1987)
described a pregnancy in a cycle showing no follicle at all on ultrasonogra-
phy. After ovulation, the corpus luteum may appear as a cystic structure, as
observed by Geisthövel e t  a l . (1983) at 2,6 – 5 days after disappearence of the
follicle. This indicates that daily observations are necessary to establish whether
or not ovulation has occurred.
Very few data are available on E2 levels. By some authors 400 pmol/l at the
end of the follicular phase is considered to be the lower limit of normal
(Lenton e t  a l . , 1982; Thomas and Cooke, 1988).
Concerning progesterone values in the normal cycle, Hull e t  a l . (1982) found
midluteal progesterone values in conception cycles between 27 - 53 nmol/l,
and between 3 - 80 nmol/l in nonconception cycles. This suggests not only a
minimum level, but also an optimal range for fertility. In their study, no
visualization of the ovaries was used. Lenton e t  a l . (1982) compared hormonal
parameters in 14 conception cycles with 27 non-conception cycles. Higher
progesterone levels were observed in the early and midluteal phase of the
conception cycles, but some influence of the very early pregnancy itself could
not be excluded. Hamilton e t  a l . (1987) more often observed LUF cycles if
progesterone remained under the 32 nmol/l level.
The lower limits of cycle normality as suggested in the literature, are summa-
rized in Table 4.
Janssen-Caspers e t  a l . (1986) postulated a decrease in diameter with 5 mm or
more as evidence for ovulation. This was later confirmed by Check e t  a l.
(1990) in HMG-stimulated cycles. A lesser than 5 mm decrease resulted in a
5.4% and a 4% pregnancy rate in first and second induction cycles, respec-
tively, compared to 13.5 and 15.7% when the decrease exceeded 5 mm. If no
decrease at all was observed, no pregnancies followed. Pierson e t  a l . (1990)
visualized the evacuation of follicle content sonographically in 9 cycles. Al-
though a great variation was seen, all follicular fluid had disappeared after a
maximum of 21 minutes. In case no follicle rupture is evident by daily ultra-
sound examinations, no pregnancies were reported by Eissa e t  a l . (1987) in 60
cycles, by Hamilton e t  a l . (1987) in 30 cycles, and by Check e t  a l . (1992) in 168
cycles. This supports the assumption that in these cycles no ovulation occurs.
23
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Table 4. Minimal criteria for a normal cycle based on data from the
literature
- Estradiol (E2) rise > 400 pmol/l (Lenton e t  a l ., 1982; Thomas and Cooke,
1988)
- Mean follicular diameter 17 mm or more at the LH peak level
(OHerlihy et  al ., 1980; Zegers-Hochschild e t  a l ., 1984; Eissa e t  a l .,
1986; Silverberg e t  a l ., 1991)
- Ovulation: at least 60% decrease of mean follicular diameter (Eissa e t
a l ., 1986) or decrease of at least 5 mm (Janssen-Caspers e t  a l ., 1986;
Check e t  a l., 1990) or disappeared or markedly decreased in size
(Thomas and Cooke, 1988; Hamilton e t  a l ., 1985)
- Ovulation within 48 hours after  the LH peak value (WHO, 1980; Hoff e t
a l ., 1983; Eissa e t  a l ., 1986)
- Serum progesterone at least 32 nmol/l in the luteal phase (Hull e t  a l .,
1982; Hamilton e t  a l ., 1987)
Subtle cycle disorders including luteinized unruptured follicle
(LUF) cycles,  as a cause of subfertility
In 1978, Marik and Hulka, as well as the group of Koninckx (Koninckx e t  a l .,
1978), published their classical work on so-called luteinized unruptured folli-
cle (LUF) cycles: cycles in which no ovulation stigmata could be seen at
laparoscopic inspection of the ovaries, after ovulation was presumed to have
occurred, followed by corpus luteum formation and progesterone production.
Koninckx e t  a l . (1978) suggested that LUF cycles could not be distinguished
from ovulatory cycles by hormonal parameters. They found ovulation stig-
mata in only 10 of 24 patients with otherwise unexplained infertility. This may
24
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well have been an overestimation, as re-epithelisation of the ovulation open-
ing appeared to take place much earlier than was supposed. Scheenjes e t  a l .
(1990) showed that the process of closure starts already after 1.5 days follow-
ing ovulation. Therefore, data obtained by laparoscopic visualization of an
ovulation stigma, should be interpreted with caution. Hamilton e t  a l . (1985),
using ultrasound, described LUF cycles with a typical pattern of follicular growth
(continuing growth after the LH surge instead of disappearance) in combina-
tion with a significant reduction of progesterone serum levels in the luteal
phase, as well as LH peak values lower than those seen in control cycles.
Normal follicular growth and normal hormonal levels were present until the
LH peak. Ovulation, however, did not occur, and in most cycles progesterone
levels remained below 32 nmol/l. Eissa e t  a l . (1987) called such cycles cyst-
like cycles and they reserved the term LUF cycle for cycles in which no
rupture of the dominant follicle occurred, but instead of continuing growth, a
decrease in follicle diameter after the LH surge was seen. In their concept of
LUF, normal luteal phase progesterone levels are present. Other authors do
not make the same distinction, and use the phrase LUF for both disorders of
ovulation. Eissa e t  a l . (1987) described another abnormal pattern, which they
called asynchronous cycles. In these cycles a shrinkage of the dominant fol-
licle occurs 24 h before the LH surge, without ovulation after the LH surge.
The same phenomenon has been described by Polan e t  a l . (1982), Lewinthal
e t  a l . (1986) and Rodin e t  a l . (1994). They observed follicles that remained
relatively small (< 16 mm) and luteinized before the onset of the LH surge.
These follicles did not ovulate after the LH surge. Petsos e t  a l . (1987) found a
shrinkage of follicles before the LH surge, as well as large cyctic follicles which
luteinized after the LH surge, without rupture. Daly e t  a l . (1985) described
small follicles that ovulated after the LH surge. In our opinion, any cycle in
which growth of a dominant follicle is present till the LH surge, and after
which luteinization occurs, but no ovulation, could be considered as a LUF
cycle. However, in the literature the phrase LUF is used to describe follicles
that do not rupture after reaching a diameter within the normal pre-ovulatory
range. To avoid confusion, we adapted this view in our review of the litera-
ture. Hamilton e t  a l . (1987) observed 10 of 14 (71%) LUF cycles if midluteal
progesterone did not reach 32 nmol/l, in contrast to 10 of 127 (7,9%) LUF
cycles when progesterone was 32 nmol/l or more. Eissa e t  a l . (1987) found as
25
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many as 48 out of 89 (54%) abnormal cycles, including 19 LUF cycles (21%)
and 21 cyst formation cycles (24%) in a group of 45 subfertile women. In
contrast, in a recent publication Leach e t  a l . (1997) found no abnormalities of
follicle growth or ovulation in 12 cycles of 12  women who met rigid criteria
for unexplained subfertility. In Table 5, the incidences of subtle cycle disor-
ders, as diagnosed by several authors using ultrasound in spontaneous cycles,
are summarized.
Anovulatory cycles like LUF, in which a pregnancy cannot occur, may repre-
sent the most extreme subtle cycle disorder. A pregnancy did not occur during
30 LUF cycles described by Hamilton e t  a l . (1987), as was the case in 60 LUF
cycles found by Eissas group (1987) and 168 LUF cycles by Check e t  a l .
(1990). It is speculative whether other disturbances like rupture of small folli-
cles, or low luteal phase levels of progesterone may represent cycles in which
a pregnancy can occur, but is less likely. The publications, summarized in
Table 5 include a total of 618 spontaneous cycles, in which a subtle cycle
abnormality has been found in 143 (23%).
Recurrence of subtle cycle disorders has only been studied in a small number
of patients (Table 6). Eissa e t  a l . (1987) described 22 normal first cycles that
were followed by 11 normal and 11 abnormal cycles; 23 abnormal first cycles
were followed by 14 abnormal and 9 normal cycles. They also found different
types of abnormalities when they followed subsequent cycles in the same
individual. Kerin e t  a l . (1983), found a low incidence of recurrence (in one of
eight women with a LUF cycle). Hamilton e t  a l . (1985) found recurrence of
LUF cycles in 6 patients. Two of them had a history of pelvic inflammatory
disease (PID), three received ovulation-induction treatment and and one pa-
tient, who was treated with ovulation induction, had a PID in the past.
Do LUF cycles also occur in healthy women who have regular cycles?. Eissa e t
a l . (1987) investigated a control group of 15 women who were considered as
normal fertile because they were treated with donor insemination, having
partners with azoospermia (n = 14) and one with a very poor sperm quality.
They found 9 out of 39 cycles (23%) abnormal, of which seven could be
classified as LUF. The two other cycles showed shrinkage of the follicle before
the LH surge, without rupture. Other authors, however, found no abnormal
cycles in their control groups (Table 7).
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Table 5. Incidence of cycle disturbances in patients with regular cycles, as diagnosed by ultrasound in spontaneous cycles in which luteinization of
the follicle occurred
Author Diagnostic group No. of cycles and
patients
Cycle disturbances
Coutts et al., 1982 Unexplained subfertility 27 cycles in 21
patients
LUF cycles in 12 of 27 cycles (44% of cycles) in 8 out of 21 patients
(38% of patients)
Polan et al., 1982 Tubal pathology 14 cycles in14
patients
5 abnormal cycles (36%): In 3 cycles small follicles that luteinized
(21%); in 2 cycles decreasing folllicle diameter, 48 h before the LH
surge, without ovulation (14%)
Tubal pathology 85 cycles in 31
patients
LUF in 4 cycles (4.7% of thecycles; 13% of the women)
Endometriosis 12 cycles in 5
patients
All cycles normal
Kerin et al., 1983
Unexplained subfertility 15 cycles in 6
patients
LUF in 1 cycle
Daly et al., 1985 Unexplained subfertility 33 cycles in 33
patients
6 abnormal cycles (18%): LUF in 3 cycles (9%); small follicles which
ovulated in 3 cycles (9%)
Lewinthal et al.,
1986
Unexplained subfertility 6 cycles in 6
patients
3 abnormal cycles (50%): LUF cycle in 1 woman; poor follicular
growth or premature luteinization in 2 women (follicles 13 and 12
mm)
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Table 5, Continued.
Total group: 89
cycles in 45
patients
Abnormalities in 48 cycles (54% of the cycles): 19 LUF cycles
(shrinkage of follicles after the LH surge) (21% of the cycles); 21 cyst
cycles (growing follicles after LH surge) (24% of the cycles); 8
asynchronous cycles (shrinkage of follicles 24 h before the LH surge)
(9% of the cycles)
Eissa et al., 1987 Unexplained subfertility; minimal
endometriosis and/or some
evidence of tubal disease
Unexplained
subfertility: 47
cycles in 22
patients
Abnormal cycles in 26 of 47 cycles (55%).
Petsos et al., 1987 Unexplained subfertility 115 cycles in 100
patients
32 abnormal cycles (28%): LUF in 16 cycles (14% of the cycles);
shrinkage of follicles, 4 days before LH surge in 12 cycles(10%); large
cysts in the follicular phase, with subsequent luteinization in 4 cycles
(3%)
Hamilton et al., 1990 Unexplained subfertility 175 cycles in 175
patients
18 LUF cycles (10%)
Rodin et al., 1994 Unexplained subfertility 35 cycles in 35
patients
16 abnormal cycles (46%): LUF in 14 cycles (40%); poor follicle growth
(<16 mm) or too early LH surge in 2 cycles (6%)
Leach et al., 1997 Unexplained subfertility 12 cycles in 12
patients
All cycles were normal and ovulatory
28 Chapter 1Table 6. Recurrence of subtle cycle disorders in patients, as diagnosed by ultrasound
Author Patients with subtle cycle
disorders who were
examined in more than 1
cycle
Cycle characteristics
Coutts et al., 1982 8 patients with
spontaneous LUF cycles
In total 12 LUF cycles in these 8 patients, which means recurrence in some of them
Polan et al., 1982 5 patients with an
abnormal spontaneous
cycle
In a second cycle 1 cycle again was abnormal
Kerin et al., 1983 8 patients with a
spontaneous LUF cycle
Recurrence of LUF in 1 out of 35 repeated cycles
Hamilton et al., 1985 27 patients with a LUF
cycle in a spontaneous or
stimulated cycle
Recurrence in 13 of 45 repeated cycles; recurrence ocurred in 6 patients
Daly et al., 1985 3 patients with a
spontaneous LUF cycle
In a second cycle 2 of the 3 patients had again a LUF cycle
Lewinthal et al.,
1986
2 patients with
spontaneous cycles with
poor follicle growth; one
patient with a LUF cycle
One patient in two successive cycles again poor follicle growth; the patient with a LUF cycle
had again a LUF cycle during 3 consecutive cycles
Eissa et al., 1987 45 patients with 2 or more
cycles
22 normal first cycles were followed by 11 normal and 11 abnormal cycles;
23 abnormal first cycles were followed by 14 abnormal and 9 normal cycles
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Table 7. Cycle characteristics in control groups, as investigated by ultrasound
Author No. of cycles and women Cycle disturbances or characteristics by ultrasound
Geisthövel et al.,
1983
6 cycles in 5 volunteers, 22-30 years of age All cycles were ovulatory
Zegers-
Hochschild et al.,
1984
28 cycles in 25 multiparous volunteers, 21-30 years 13 conception cycles, 15 non-conception cycles. All cycles were
ovulatory
Eissa et al., 1987 39 cycles in 15 women, treated with donor
insemination, 23-40 years (median 31)
9 abnormal cycles (23%): 7 LUF cycles (18%); 2  asynchronous cycles
Hamilton et al.,
1990
43 cycles in 43 volunteers, 18-36 years (median 26);
at least half of them have conceived since
All cycles were ovulatory
Bakos et al., 1994 16 cycles in 16 volunteers; most of them had been
pregnant
All cycles were ovulatory
Leach et al., 1997 12 cycles in 12 volunteers with proven fertility, 25-40
years (mean 32.8)
All cycles were ovulatory
30 Chapter 1Table 8. Treatment of LUF and other subtle cycle disorders in subfertile women with regular cycles
Author Cycle disorder No. of patients Treatment No. of patients with
ovulatory cycles
No. of patients
pregnant
Recurrent LUF in 3 cycles 9 Clomiphene citrate or
hMG/hCG
9 8, after 1-6 ovulatory
cycles (mean 2.4)
Daly, 1989
LUF, rupture of small
follicles, abnormal follicle
growth, in 2 or more cycles
16 Clomiphene citrate,
hMG/hCG or
dexamethasone
(1 patient)
13 11, after 1-5 ovulatory
cycles (mean 2.6)
Check et al., 1992 LUF, premature
luteinization, in 2
consecutive cycles
46 Clomiphene citrate,
hCG, hMG/hCH; in
total 198 cycles
45 24 (12.1%/cycle)
Rodin et al., 1994 LUF in a first cycle 14 One clomiphene citrate-
stimulated cycle
11
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Subtle cycle disorders in unexplained  subfertility
Special attention has been paid to the cycles of patients diagnosed as having
unexplained subfertility. In these patients, even after an extensive diagnostic
work-up, no cause of the infertility can be identified. It seems rational to
search for subtle cycle disorders in these women. The prevalence of unex-
plained subfertility in the literature ranges from 8% to 37% (Leach e t  a l ., 1997).
Differences not only depend on the levels of investigation, but also on charac-
teristics of the patients groups and referral patterns. Publications on disorders
of follicle growth and ovulation in unexplained infertility are included in Ta-
ble 5. The incidences has been reported to range from 0% (Leach e t  a l ., 1997)
to as much as 54% (Eissa e t  a l ., 1987) and do not differ from those in the total
group of subfertile women. In Table 5 within the unexplained group, 465
cycles are summarized, in which 112 subtle cycle disorders (24%) were ob-
served.
Summarizing, subtle cycle disorders, especially LUF, rarely occur in normal,
fertile women, in contrast to subfertile patients in which they occur much
more often. It is reasonable to assume that such cycle disturbances explain at
least partly, the subfertility in such couples. A comparison can be made with
oligomenorrhoeic patients. Although most of them will ovulate sometimes,
the number of ovulatory cycles is less than normal. There is general agree-
ment that these patients benefit from ovulation induction treatment. Patients
with one or more LUF cycles may have a diminished probability to conceive,
although this has not been proven in large longitudinal studies. It is our im-
pression that some women may benefit from diagnosing subtle cycle disor-
ders.
The etiology of subtle cycle disorders has not been established. In rats, LUF
cycles can be induced by manipulating the LH surge (Plas-Roser e t  a l ., 1985;
Mattheij e t  a l ., 1995), and local (ovarian) disorders of prostaglandin synthesis
may play a role (Plas-Roser e t  a l ., 1985). In women, a central cause has been
suggested because a blunted LH surge has been found in LUF cycles (Hamil-
ton e t  a l .,1985; 1987). However, arguments for a peripheral (ovarian) cause
are suggested by the same group (Hamilton e t  a l ., 1985) because they ob-
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served recurrence of LUF especially in patients with a history of PID. Recur-
rent LUF cycles during ovulation induction could have an extra-ovarian as
well as an ovarian origin.
Treatment, with the intention to reverse the typical abnormality that has been
found in a patient (for instance enhancing the LH surge in case of a LUF cycle,
with hCG), seems not indicated, because in different cycles different distur-
bances may occur (Eissa e t  a l ., 1987). Some authors report on treatment of
patients in whom LUF cycles were found by use of ultrasound, with regimens
that are used in patients with oligo- or amenorrhoea, who wish to conceive.
Results are summarized in Table 8. More than half of the patients became
pregnant. Although these treatments seem reasonably successful, it remains
unknown whether the reported pregnancies are treatment-dependent, or treat-
ment-independent. Randomized studies comparing treatment cycles with un-
treated controls have not been published.
Subtle cycle disorders during ovulation induction treatment
Few studies have addressed cycle characteristics and cycle disorders during
ovulation induction in oligo- or amenorrhoeic patients with clomiphene citrate,
gonadotropins or pulsatile GnRH. The occurrence of multifollicular growth
and the resulting multiple gestations are known from the initial use of these
drugs. In Table 9, data on treatment of cycle disorders that are subtle, are
summarized. These preliminary data indicate that LUF cycles may occur in a
significant part of the cycles. Check e t  a l . (1990) noted that almost all patients
with a LUF in their first cycle showed recurrence in the second one. In cycles
that are stimulated with HMG, ovulation rates depend on follicle diameter.
Silverberg e t  a l . (1991) followed the destiny of all follicles in controlled
hyperstimulation cycles before IUI. Follicles = 17 mm on the day of hCG-
administration had a 13-fold incidence of ovulation compared to follicles = 16
mm. Follicles = 14 mm rarely ovulated. Clomiphene citrate is also used to
induce controlled hyperstimulation in patients with regular cycles, in combi-
nation with IUI. A remarkable observation was made by Randall and Templeton
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(1991)  who st imulated 24 women with unexpla ined subfert i l i ty  and
sonographically proven ovulatory cycles. In cycles stimulated with CC, six of
these women had a LUF cycle.
34 Chapter 1Table 9. Cycle characteristics of ovulation induction cycles in women with oligomenorrhoea or amenorrhoea
Author No. of cycles and women Cycle disturbances or characteristics by ultrasound
45 cycles stimulated with clomiphene citrate 6 LUF cycles (13%)
14 gonadotropin-stimulated cycles No LUF cycles
Hamilton et al.,
1987
10 GnRH-stimulated cycles 4 LUf cycles (40%)
First cycles in 220 patients, stimulated with HMG 16 LUF cycles (7%)Check et al., 1990
Second cycles in 197 patients 13 LUF cycles (7%)
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The luteal phase defect
The luteal phase of the normal menstrual cycle starts at the time of ovulation
and ends at the onset of menstruation. Under the influence of progesterone
produced by the corpus luteum secretory changes are induced in the en-
dometrium, which has been proliferated under the influence of estrogens. A
secretory endometrium is a prerequisite for implantation of the early embryo
and for maintenance of pregnancy (Csapo and Pulkkinen, 1978). It has been
assumed that the luteal phase may be abnormal, a so-called luteal phase de-
fect (LPD), being a cause of infertility (Jones, 1976). LPD is also known as
luteal phase deficiency (Balasch e t  a l ., 1986), luteal phase inadequacy (Murthy
e t  a l ., 1970) or luteal phase insufficiency (Taubert, 1978). LPD is a controver-
sial issue, much so because of a lack of consensus in its diagnostic criteria (Li
and Cooke, 1991; Castelbaum and Lessey, 1995). In our opinion, a LPD-diag-
nosis should only be suggested in an o v u l a t o r y cycle. For evaluating LPD
several methods have been used, including basal body temperature, sonographic
measurement of endometrial thickness, histological dating of the endometrium
(Noyes e t  a l ., 1950) and measurements of progesterone in plasma (Hull e t  a l .,
1982) or saliva (Walker e t  a l ., 1981). Timing and interpretation of histological
dating and of (one or repeated) progesterone assays are a matter of ongoing
debate (Li and Cooke, 1991; Castelbaum and Lessey, 1995). Whether LPD
really exists has not yet been esthablished. However, in some studies (Li e t  a l .,
1991), in infertile populations a significantly higher prevalence (diagnosed by
dating of endometrial biopsies) has been found than in fertile control
populations. A follow-up study suggests that women in whom LPD has been
diagnosed, have reduced fertility compared to women without LPD (Klentzeris
e t  a l ., 1990). It has been suggested that LPD could be the consequence of an
aberrant follicular phase, in which inappropriate estrogen production results
in inadequate priming of the endometrium (DiZerega  and Hodgen, 1981).
However, this could not be confirmed by others (Li e t  a l ., 1991). Subnormal
progesterone production by the corpus luteum, is another possibility, though
unlikely, as Li e t  a l . (1991) found that in a majority of cases with retarded
endometrial development progesterone levels were normal. Therefore, an
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abnormal response of the endometrium to progesterone has been considered
the most likely cause of LPD (Li and Cooke, 1991). Many methods of treatment
for LPD have been used, including the administration of progesterone, clomi-
phene citrate, FSH, bromocriptine and pulsatile GnRH. None of these treat-
ments is based on a properly conducted clinical trial including a sufficient
number of patients and controls (Karamardian and Grimes, 1992). The only
controlled trial on the use of progesterone (Balasch e t  a l ., 1982) included 44
infertile patients with histologically documented inadequate luteal phase who
were randomly divided into 3 groups. Sixteen patients received progesterone
as vaginal suppositories, 16 dehydrogesterone orally, and 12 no treatment.
Both treatment regimens corrected the inadequate luteal phase compared to
the controls (P < 0.001). Pregnancy rates showed a trend in favour of treat-
ment, but the differences were not statistically significant (five pregnancies in
the progesterone-group, as well as in the dehydrogesterone group; two in the
control group; P = 0.66). To be able to show a difference, many more patients
would have been required (Karamardian and Grimes, 1992). The most ra-
tional treatment should be aimed at improving the responsiveness of the en-
dometrium to progesterone (Li and Cooke, 1991). Women above age 40 may
have diminished uterine receptivity for nidation of embryos. In oocyte dona-
tion using oocytes of young donors, implantation rates could be enhanced by
applying supraphysiological progesterone replacement (Meldrum, 1993). Pre-
liminary results suggest that low-dose aspirin may improve implantation rates
in oocyte donation recipients with thin endometrium (Wada 1994, Weckstein
1997).
Concluding remarks
Much is known of the anatomy and normal function of the organs that govern
the menstrual cycle. Hormonal and other signals, induction of hormone
receptors, and feedback systems that regulate follicle growth and ovulation
have been studied extensively. However, it seems almost impossible to de-
scribe the hormonal and ultrasonic conditions a cycle must fulfill to be consid-
ered as normal. Hormonal levels as well as follicle growth vary greatly be-
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tween women, and in the same women, between cycles. In subfertile women
with regular cycles more often cycle disorders have been found than in con-
trols. Cycles can be monitored by determination of several hormones through-
out the cycle, and by ultrasound scans of the ovaries. It is still not clear how
often cycle abnormalities occur in a general subfertile population, and how
often they contribute to the subfertility of these women. The costs which are
necessary for diagnosing such disorders have not been calculated so far. Moreo-
ver, the benefits of treatment of subtle cycle disorders are unknown. In women
with oligo- or amenorrhoea, ovulation induction is an established treatment,
but how often ovulation disorders are induced by the treatment, is not clear.
In patients who are treated with CC, pregnancy rates are less than expected
from the supposed ovulation rates (Hammond e t  a l ., 1983, 1984). The cause of
this discrepancy is still unknown.
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 Abstract
Female fertility decreases with age. Postponement of childbearing, which is a
remarkable demographic trend in Western countries, therefore leads to an
increasing proportion of subfertile couples. The stock of primordial follicles is
established during early fetal life and decreases exponentially thereafter by a
process of follicle atresia. According to the so-called ovarian hypothesis, a
decrease in both quantity and quality of the remaining resting follicle pool
dictates several reproductive events including the beginning of subfertility, the
end of fertility, the age of transition from cycle regularity to cycle irregularity,
and the age at menopause. Age at menopause is the only clearly recognizable
reproductive event and marks the exhaustion of follicular reserve. The same
variation of age at menopause is probably also present for the preceding
reproductive events. Why individual follicles start to develop, is unknown.
Follicle stimulating hormone (FSH), which is necessary for growth of the
selectable follicles, and maturation of the dominant follicle, may play an addi-
tional role. The same factors (mainly genetic) that determine age at meno-
pause may also determine reproductive aging. Though a decrease of fertility
starts relatively early in the reproductive life of a woman, hormonal changes
as well as ovulation disorders and irregular cycles occur much later. The first
endocrine sign of reproductive aging is a monotropic rise of early follicular
FSH levels, which becomes clear after age 40, with a large overlap with levels
in young women. The patterns of luteinizing hormone (LH), estradiol (E
2
) and
progesterone do not change with age, as do follicle growth patterns. Inhibin B
shows a higher rise after the LH peak in younger women, The relevance of
this rise is not clear. Until the primordial follicle pool is almost exhausted,
hormonal parameters do not seem to be reliable markers of reproductive
aging.
1.   Introduction
Delaying childbearing is a remarkable demographic trend in all Western
countries [1,2], which started in the early 1970s when oral contraceptives became
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widely available. From that time onwards, having children could be planned
and, as a result, postponed in order to complete an education or give preference
to a career. Postponement of childbearing, however, inevitably leads to attempts
to become pregnant at a more advanced age. This trend considerably contributes
to the increasing proportion of subfertile couples [2]. Van Noord-Zaadstra et al
[3] found a rapid decline of the monthly chance to have a pregnancy resulting
in the birth of a healthy child, after the age of 30 years in couples who tried to
conceive with the aid of donor-sperm insemination. At 35 years, this monthly
chance was halved compared to the period before age 30, and at 38 years, it
had dropped to one-quarter. A further decrease of fecundity is illustrated by
the mean age at the birth of the last child (40-41 years), found in natural
populations when no contraception was used [4,5]. Other reflections of
diminishing fecundity after age 37-38 years are a lower implantation rate per
embryo in in-vitro fertilisation (IVF) [6], as well as a lower probability of a
pregnancy after IVF [7]. Age-related declining fecundity  is a result not only of
a decreasing monthly fertility rate, but also of an increasing abortion rate,
rising from about 10% before age 30 to 45% at age 45 [8].
At the end of female fertility, most women still have regular menstrual cycles
with progesterone production in the luteal phase, as suggested by a biphasic
basal body temperature. Only at about the age of 45 years do menstrual cycles
become irregular, some 6 years before menopausal age [9], which comes at a
mean age of 50-51 years in Western countries.
2 . Concepts of reproductive aging
The stock of primordial follicles (oocytes surrounded by granulosa cells) in
the ovaries, established during fetal life, has to serve the reproductive needs of
a woman for the rest of her life. At about 20 weeks of gestation, a maximum
number of about 7 million has been reached [10-13]. Only a few hundreds will
eventually mature to the stage of dominance, and ovulate. All the others -the
vast majority- will become atretic by apoptosis [11,14]. This process of atresia
starts already before birth. At birth and at menarche, about 1 000 000 and 300
000 are left, respectively. At a mean age of 37-38 years, only about 25 000
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resting follicles are present in the ovaries. Thereafter, the curve follows a
biphasic pattern because of an acceleration of the disappearance of follicles
[11]. Menstrual cycles become irregular at about age 45 [9], which is on average
6 years before menopause. Cycle irregularity appears to be dependent on the
number of remaining follicles and not on age [12]. This is supported by the
finding that the time interval between the beginning of cycle irregularity and
age at menopause is 6-7 years, regardless of the age at menopause [15]. When
almost no follicles are left, menopause occurs.
According to the so-called ovarian hypothesis, decreasing fertility after age 30
is dictated by the decreasing quantity [11] and quality [16-18] of the resting
follicle pool. Whether the differentiation of oocyte quality is already established
during fetal life or whether quality deteriorates by accumulation of damage
thereafter is a matter of scientific debate [19]. The remarkably good result of
IVF in (pre)menopausal women when using oocytes of young donors further
emphasizes that the oocyte rather than the endometrium dictates the
age-dependent fertility loss [20]. Although the ovarian hypothesis is widely
supported, an additional role of the hypothalamus cannot be ruled out. The
so-called neuro-endocrine hypothesis of reproductive aging considers aging
of the hypothalamus as the main initiator of a cascade of events leading to
menopause. Reproductive aging is considered as a dysregulation of the GnRH
pulse generator by a progressive lack of neuro-chemical control from other
brain centers. [21]. One of the first signs of this transition is the monotropic rise
of FSH during the early follicular phase, which causes the acceleration of
follicle depletion. In a recent study by Matt et al. [22], changes in LH-pulse
patterns were demonstrated in regularly cycling women of 39 or older as
compared to a younger age group. These alterations may well be the first sign
of hypothalamic aging.
In Fig. 1, the decreasing resting follicle pool as schematically depicted from
the work by Faddy et al. [11] and the corresponding reproductive events are
summarized. This figure suggests that the decreasing resting follicle pool is
closely related to age-related reproductive events including age at menopause.
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Fig. 1. Decreasing follicle pool and the corresponding reproductive events.
The dynamics of follicle growth from the resting or primordial stage until
ovulation is shown in Fig.2 and is based on the work of Gougeon [13]. Why,
after a state of quiescence, which may last several decades, individual follicles
start to grow, remains a mystery. The entire process from the initiation of
growth until ovulation takes at least half a year [13]. However, the vast majority
of follicles will become atretic by apoptosis at some stage of development
before the final stage of maturation for ovulation has been reached. For example,
antral follicles measuring 2-10 mm will become atretic, unless rescued by the
intercycle FSH rise. From this cohort of so-called selectable foIlicles, which
can be visualized by sonography during the early follicular phase, the dominant
follicle destined to ovulate will be selected during the first 10 days of the
menstrual cycle. The continuous initiation of growth of resting follicles results
in an increasing depletion and, ultimately, exhaustion, of the entire resting
follicle pool. Whether resting follicles can go directly into atresia before initiation
of early growth, is still unknown.
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Fig. 2. Various follicle stages in relation to the follicle diameter and the phase
and time of growth in women with normal, menstrual cycles.
Development of the selectable follicles and the maturation of the dominant
follicle is only possible in the presence of FSH. Which factors determine the
initiation of growth of the resting follicles is unknown, although FSH may play
an additional role. It is certain that FSH is no sine qua non because selectable
follicles are present in circumstances in which FSH levels are very low [23,24]
or absent, as in Kallmann patients [25,26]. There is, however, some evidence
for a facilitating role of FSH in initiating follicular growth or stimulating early
follicular growth. For example, Zheng et al. [27] showed that FSH mRNA is
expressed in human resting follicles, which suggests a possible influence of
FSH. Very low or absent FSH levels were found to inhibit follicular depletion
in animals [28,29] and to inhibit cyclophosphamide-induced follicular depletion
in monkeys [30]. A stimulating influence of FSH is also suggested by the
accelerated depletion of the resting follicle pool once FSH levels start to rise
[11].
Atresia
Resting
(0.03 mm)
Preantral
(0.1-0.2 mm)
Antral
(0.2-2 mm)
Selectable
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Using a mathematical model, Faddy and Gosden [31] provided estimates of the
daily number of follicles entering the growth phase. They found a dramatic
drop of 45 follicles in the age group 20-30 years to six follicles  in age group
38-45 years. The question of how many of these will reach the selectable stage
is addressed by Scheffer et al. [32]. They found that the mean number of
sonographically detectable follicles with a diameter of at least 2 mm in the
early follicular phase decreased less steeply. This may indicate that the fraction
of follicles at the selectable stage increases as the size of the total follicle pool
decreases: at an older age less follicles enter the growth phase, but relatively
more of them survive. Data from other research groups confirm this concept
[33-35]. Scheffer et al. [32] also found a high correlation between the number
of selectable follicles and calender age in 140 regularly cycling volunteers with
proven fertility. Whether assessments of the number of antral follicles can be
used as a measure of reproductive age in women with subfertility, or as a
prognosticator of the ovarian response to controlled ovarian hyperstimulation,
deserves further study.
3.   Age at menopause as a key event of reproductive aging
All ages mentioned so far, and presented in Fig. 1, are given as mean or
median values. Menopause, for example, comes at a mean age of 51 in most
Western countries, but shows an enormous variation. It is the only clearly
recognizable reproductive event and marks the definite exhaustion of follicular
reserve. We hypothesize that the sequence of preceding reproductive events -
the beginning of subfertility, the beginning of infertility, and the transition
from cycle regularity to irregularity- is closely related to age at menopause and
shows a similar age variation. The cumulative distribution of age at menopause
is depicted by the curve at the right in Fig. 3 and is based on data by Treloar
[9].
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Fig. 3. Cumulative age at menopause (1), age of transition from cycle regularity
to irregularity (2), the end of fertility (3) and the beginning of subfertility (4).
Transition of cycle regularity to irregularity has been shown to occur at a
mean age of 45-46. The mean age of last delivery in natural populations,
which is likely to reflect the end of female fertility, has been found to occur at
age 40-41 [4,5] and the beginning of subfertility at about 31 years of age [3] or
even earlier [5]. If, indeed, these reproductive events have a similar age variation
to menopause, cumulative age at menopause, age at transition from cycle
regularity to irregularity, end of female fertility and beginning of subfertility
can be presented as shown in Fig. 3 by curves 2, 3, and 4, respectively. This
would mean that a woman who will have her menopause, for example, at age
45, starts to be subfertile at age 26 and is already infertile at age 36 while her
cycles are still regular and seemingly normal. Delay of childbearing can impose
great problems in such women.
If age at menopause is a reliable marker of reproductive aging, the same
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factors that determine age at menopause also determine reproductive aging.
Several factors are known to influence age at menopause. They can be divided
in lifestyle factors, factors related to fecundity and possibly events during
intrauterine life. For a review of this subject, see Ref. [36].
In spite of the fact that most of these factors show a highly significant relation
with age at menopause, multivariate analysis reveals that only 1-3% of the
variance of age at menopause is explained by lifestyle and fecundity-related
factors [37]. Genetic factors seem a much more likely explanation. A correlation
is apparent between age at menopause of mothers and daughters [38] and also
between sisters with premature ovarian failure [39]. In a study of 361 sisters
and 5881 women from an at-random population, we demonstrated that more
than 80% of the observed differences in the age of menopause have a genetic
origin commonly referred to as heritability (J.P. de Bruin et al., submitted for
publication). Two studies on menopausal ages in identical twins [40,41] come
to similar conclusions. If, indeed, the age at menopause and the preceding
reproductive events are closely related, it is most likely that they are determined
by the same genetic factors.
4. Endocrine changes and follicular development related to aging
In the following section, we give an overview of age-related changes in the
gonadotropic hormones [follicle stimulating hormone (FSH) and luteinizing
hormone (LH)], the main hormones secreted by the ovaries during the hormonal
cycle [estradiol (E
2
), and progesterone] and the peptide hormone inhibin. Some
details of follicular development in relation to hormonal changes are briefly
discussed.
4.1. Fol l i c l e  s t imulat ing  hormone (FSH)
The first endocrine sign of reproductive aging is a monotropic rise of early
follicular FSH levels in regularly cycling women between age 35 and 40 [42-
47]. Schipper et al. [48] did not observe any age-related difference in early
follicular FSH in 38 strictly regularly cycling volunteers, but this may be explained
by the mainly young age of these volunteers. Ahmed Ebbiari et al. [49] described
an early follicular FSH rise from age 27 years on, in a large group of patients
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with a fertility problem. In this patient group, however, a selection of women
with (still hidden) ovarian failure may have been included. In 165 proven
fertile volunteers between the ages of 25 and 47 years, we also found a rise of
early follicular FSH related to age (R= 0.25, P = 0.001) (Fig. 4).
Fig. 4. Early follicular phase FSH levels in 165 volunteers with regular menstrual
cycles. (R = 0.25, P = 0.001).
However, this correlation was strongly influenced by the elderly women, because
below age 40, the correlation was much weaker and did not reach statistical
significance (R = 0.15, P = 0.125). Moreover, FSH levels in older women show
a large overlap with levels in young women. This observation is in line with
the threshold concept of Brown [50], which suggests that women have an
individual FSH level above which follicles are stimulated for further growth.
This means that a moderately elevated early follicular FSH either may reflect a
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high but physiological threshold level or may be a sign of early ovarian failure.
The FSH rise is also seen in other phases of the cycle [42,43,45,47]. Our data
from 81 proven fertile volunteers of whom we followed a cycle by ultrasound
measurements of follicle development as well as by hormone assays (Fig. 5)
show a higher mean FSH level in the older group during the follicular phase
including the day of the LH peak, although the differences do not reach statistical
difference. The above-mentioned studies are all transversal studies. Subtle
longitudinal FSH changes within the normal range may well occur much earlier.
Fig. 5. Mean FSH levels in three age groups of 81 volunteers, in relation to the
day of the LH peak.
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4.2. Lute in iz ing  hormone (LH)
In normal volunteers, several research groups were able to confirm an LH rise
with age [42-46], except Klein et al. [47], who found no difference. In our
group of volunteers we found equal LH levels in the early follicular, late
follicular and luteal phase. The  LH peak levels during the LH surge were
slightly higher in the youngest group compared to the two other groups,
however, without a statistically significant difference (Fig. 6). In a patient group,
Ahmed Ebbiari et al. [49] described an early follicular rise of LH with age, but
5-10 years later than the age-related FSH rise.
Fig. 6. Mean LH levels in three age groups of 81 volunteers, in relation to the
day of the LH peak.
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4.3. Estradiol (E
2
)
Inconsistent patterns have been reported on early follicular estradiol levels at
older ages. Sherman et al. [42] found a decrease, Reyes et al. [43] no change,
whereas in contrast, Musey et al. [44] and Klein et al. [47] found early follicular
E
2
 levels that were increased in older, compared to younger women. Fig. 7
shows the mean E
2
 concentrations plotted against the day of the LH peak level
in our group of volunteers. No differences are observed between the three
age groups.
Fig. 7. Mean estradiol levels in three age groups of 81 volunteers, in relation to
the day of the LH peak.
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4.4. P r o g e s t e r o n e
Progesterone levels do not appear to show any clear changes with increasing
age. As well as a decrease [43], no change [42,46] as a tendency to increase
with age [47] have been described. The data of our own group have not yet
been analyzed.
4.5. Inh ib in  B
Inhibin is a heterodimer secreted by granulosacells, which is able to selectively
inhibit FSH secretion. Circulating forms of inhibin include inhibin A (composed
of a and ßA subunits) and inhibin B (composed of a and ßB subunits). During
the normal menstrual cycle, a significant inverse correlation is present between
early follicular FSH and inhibin B [51]. Inhibin A rises parallel to E
2
, and is
thought to reflect dominant follicle function. Thus, inhibin B seems mainly to
be related to early follicular growth and therefore may be a marker of the age-
dependent decrease of the follicular pool [52]. In our study of regularly cycling
proven fertile women, aged 25-47 years, we also found an inverse, but rather
weak, correlation between inhibin B on cycle day 3 versus age (R = 0.12, P =
0.14, n  = 164). An unexpected observation in our group of volunteer women,
as seen during and after the LH surge, is shown in Fig. 8. Comparable levels of
Inhibin B were found during the early follicular phase and on the day of the
LH peak value, irrespective of age. One day later, however, Inhibin B shows a
rise in the younger compared to the older women (22-33 years versus 38-46
years: p  = 0.002). This suggests an age-related difference in the ability of peri-
ovulatory follicles  to secrete inhibin B as a  response  to the midcycle
gonadotropin surge. It is not known whether such a different response is of
any physiological or clinical relevance.
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Fig. 8. Mean inhibin B levels in three age groups of 81 volunteers in the early
follicular phase, on the day of the LH peak and the day after the LH peak.
4.6. Fo l l i c l e  d e v e l o pmen t
In Fig. 9, the mean diameters of the developing follicles, as calculated from
vaginal-ultrasound measurements of three perpendicular dimensions of the
leading follicles, are shown. Displayed against the number of days preceding
the LH peak, there is no difference between the curves of the three age groups
among our volunteers. This suggests that the follicle growth pattern does not
change with age. The shorter follicular phase in older women, as found by
Treloar [9], can possibly be explained by an earlier start of follicle growth in
this age group.
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Fig. 9. Mean follicle diameters in three age groups of 81 volunteers, in relation
to the day of the LH peak.
5 . Concluding remarks
It is generally accepted that reproductive aging is directly related to the remains
of the stock of primordial follicles, which is established during fetal life (ovarian
hypothesis). However, whether aging of the hypothalamus plays an additional
role, cannot be ruled out (neuro-endocrine hypothesis). The follicle pool
progressively empties as a woman grows older and is (almost) completely
exhausted when menopause is reached. Throughout a womans life until
menopause, follicles leave this pool by initiation of growth [13]. Apparently,
the decrease in oocyte quantity parallels decrease in oocyte quality, because
in addition to a lower probability of conceiving, the incidence of spontaneous
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abortions, chromosomal abberations and congenital malformations progressively
increases as a woman grows older. Subfertility only starts at a mean age of
about 30-31, when the remaining follicle reserve has become a fraction of its
original number. Thereafter, a further decrease in both oocyte quantity and
quality dictates the subsequent reproductive events: the end of fertility, the
beginning of cycle irregularity and, when almost no follicles are left, the
occurrence of menopause. The remarkable variation of age at menopause is
probably also present for the preceding reproductive events and is mainly
genetically determined.
Though a decrease of fertility starts relatively early in the reproductive life of
a woman, hormonal changes as well as ovulation disorders are observed much
later. From age 41 to 46, a period during which a majority of women are
already (or become) infertile, cycles usually are still regular, while not only
estradiol and progesterone levels, but also follicular growth and ovulation (as
visualized by ultrasound), appear to be normal. Follicular growth including
ovulation, and the aforementioned hormone levels, can be considered as a
reflection of granulosa cell function, while oocyte quality determines a womans
fertility. Apparently, changes in oocyte quality and granulosa cell function are
the results of different, albeit related, processes, the latter being preserved
much longer than the former. Only at a median age of about 46 when the
primordial follicle pool is almost exhausted [11], do normal cycle characteristics
disappear [53]. At this time the size of the antral follicle cohort arriving in the
inter-cycle FSH window [54], apparently becomes too small to safeguard the
normal development of a dominant follicle. Until that age, hormonal parameters
do not seem to be reliable markers of reproductive aging.
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Chapter 3. Aims and outline of the thesis
Introduction
In Chapter 1, a review was given on the present knowledge of cycle distur-
bances in regularly cycling subfertile women, and at the end some questions
that are still open, were summarized. In Chapter 2,  we discussed the current
knowledge of the age-related decline of female fertility, and changes of hor-
monal patterns with age, also in women with still seemingly normal and regu-
lar cycles. It is still not clear whether disorders of ovulation, disturbed follicle
growth patterns, abnormal hormonal regulation or altered time-interrelations
between these events contribute to such a decline.
Aims of the thesis
The aims of the thesis are:
1. To estimate the incidence of subtle ovulation disorders in women with
infertility problems, who have a regular menstrual cycle and a biphasic
BBT, and:
To investigate whether ovulation disorders can be predicted by low
luteal phase serum progesterone levels, in subfertile women with regular
cycles;
2. To evaluate the costs, necessary to diagnose subtle ovulation disorders
in women with a history of regular menstrual cycles;
3. To investigate whether ovulation disorders, like LUF cycles, or abnor-
mal hormonal patterns, occur more often in clomiphene citrate-stimu-
lated seemingly ovulatory cycles compared to cycles of age-matched
proven fertile women;
4. To obtain reference values for cycle normality from a group of rela-
tively young, proven fertile women who have regular menstrual cy-
cles, and:
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To eva luate  whether  fo l l i c le  growth ,  ovula t ion ,  endometr ia l
development and hormonal patterns in proven fertile older women
differ from the reference group, and whether differences, if present,
may explain, or contribute to, the age-related loss of fertility.
Outline of the following chapters
In Chapter 4, we investigate whether serum progesterone levels in the luteal
phase that remain below a pre-set level during two subsequent cycles, can
predict the occurrence of subtle ovulation disorders in a following cycle.
Chapter 5 describes the costs of diagnosing ovulation disorders in subfertile
women who have regular cycles, by different methods, and discusses the
benefits for the patients of such a diagnostic approach and subsequent treat-
ment.
In Chapter 6, we describe hormonal patterns and follicle development and
ovulation in cycles of women with oligo- or amenorrhoea, who are treated
with the ovulation-inducing agent clomiphene citrate. The results are com-
pared with those of an age-matched control group of proven fertile women.
In Chapter 7, several ultrasound and hormonal parameters are investigated
during the cycles of a group of proven fertile volunteers, who have an age in
which fertility can be expected to be greatly reduced. Their cycles are com-
pared with those of a relatively young proven fertile women who served as a
reference.
In Chapter 8, the results and conclusions of the thesis are discussed and sum-
marized. Directions for future research are indicated.
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Abstract
Serial hormonal and ultrasound measurements were performed in a group of
50 infertile  women with regular menstrual cycles of normal length, and evi-
dence of luteinization by measurement of biphasic basal body temperature
(BBT). The progesterone levels however, remained below a critical threshold
of 32 nmol/l  (1 nmol/l = 0,315 ng/ml) in two cycles.
In 50 cycles, 25 showed definite abnormalities. In 16 other cycles, ovulation
was observed, but relatively low luteal progesterone followed. Although preg-
nancy in these 16 cycles could be less likely, the real significance of this
finding is questionable. The etiology of these subtle cycle anomalies is not
clear and may be multifactorial. For this reason, no therapy other than use of
ovulation-inducing agents by trial and error is as yet available. Preliminary
results indicate that cycle disturbances may persist under ovulation induction,
even though progesterone levels are normalized.
Introduction
Although much is known about hormonal and ultrasonic events in the men-
strual cycle, no clear data to judge the borders of normality are available. The
question arises as to what the characteristics of a normal cycle are.
Follicular growth has been extensively studied. OHerlihy and colleagues1 found
a pre-ovulatory range of mean follicular diameter of 17-25 mm, and a good
correlation between the calculated volume on the basis of ultrasound, and the
volume of aspirated follicular fluid. Other groups found similar pre-ovulatory
follicle diameters. Zegers-Hochschild and colleagues2 observed a 95% interval
of 18.3-21.0 mm in 13 conception cycles; Eissa and co-workers3 a range of 18-
25 mm in 12 spontaneous conception cycles. From ovulation-induction stud-
ies it is known that follicles of 17 mm or larger are more likely to ovulate after
administration of human chorionic gonadotropin (hCG) than are follicles of
smaller diameter4. Follicle rupture is presumed if the follicle has disappeared
or markedly decreased in size5,6. Fluid in the pouch of Douglas, being con-
firmatory evidence, is not always seen. Eissa and co-workers3 observed a de-
crease in diameter of at least 89% in nine conception cycles, within 48 h after
the luteinizing hormone (LH) peak value. They consider a decrease in mean
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follicle diameter of at least 60% as evidence of ovulation7. The process of
follicle rupture is largely unstudied. Pierson and co-workers8 followed the
evacuation of follicle content ultrasonographically in nine cycles. Although a
great variability was seen, after a maximum of 21 minutes all follicular fluid
was gone. If no follicle rupture is evident, no pregnancies are reported by
Eissa and associates7 in 60 cycles, and by Hamilton and co-workers9 in 30
cycles, supporting the reliability of this diagnosis. However, good imaging of
the ovaries is a prerequisite, as pregnancies have occurred in cycles showing
no follicle at all on ultrasonography. After ovulation, the corpus luteum may
appear as a cystic structure, as observed by Geisthövel and associates10 at 2.6
– 5 days after disappearence of the follicle, stressing the need for daily obser-
vations.
In the literature, very few data are reported with regard to E2 levels. 400
pmol/l at the end of the follicular phase is considered to be the lower limit of
normal 5,11.
Concerning progesterone values in the normal cycle, in conception cycles
Hull and colleagues12 found mid-luteal progesterone values of 27 - 53 nmol/l
as compared to 3 - 80 nmol/l in non-conception cycles. This suggests not only
a minimum level, but also an optimal range for fertility. In their study, no
visualization of the ovaries was used. Hamilton and co-workers9 observed 10
of 14 (71%) luteinized unruptured follicle (LUF) cycles if progesterone did not
reach 32 nmol/l, in contrast to no more than 10 of 127 (7,9%) abnormal cycles
when progesterone was 32 nmol/l or more.
On the basis of the abovementioned data from the literature, we defined the
lower limits of normality using the criteria as shown in Table 1.
Usually, women who menstruate regularly and have a biphasic basal body
temperature (BBT) are considered to have ovulatory cycles. However, several
kinds of ovulation disturbances have been described in such patients. To de-
tect these ovulation disorders, extensive analysis of at least one cycle would
be necessary. As mentioned above, plasma progesterone levels might be used
as a marker to identify these patients. The present study was undertaken to
investigate if ovulation disorders can be predicted by low luteal phase serum
progesterone levels, and to estimate the minimal incidence of ovulation disor-
ders in women with infertility problems who have a regular menstrual cycle
and biphasic BBT.
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Table 1   Minimal criteria for normal cycle
Estradiol (E2) rise of > 400 pmol/l
Mean follicular diameter of 17 mm or more at the
luteinizing hormone peak level
Ovulation (at least 60% decrease of mean follicular
diameter) within 48 h after  the luteinizing hormone
peak
Serum progesterone level of at least 32 nmol/l in the
luteal phase
Materials and methods
The study was conducted at the Department of Reproductive Endocrinology
and Fertility of the University Hospital Utrecht.
As a part of the infertility workup in regular cycling women (24-36 days
duration) the quality of the menstrual cycle was assessed by BBT records and
measurements of serum progesterone levels in the second half of the cycle.
Starting 16 days before the expected day of menstruation, blood was drawn
with intervals of 3 to 4 days until menstruation. In the first sample, prolactin
also was assayed. If no progesterone value of 32 nmol/l (1 nmol/l = 0,315 ng/
ml) or higher was measured, the procedure was repeated in a following cycle.
If again the level of 32 nmol/l was not reached, the patient was scheduled for
a so-called extended cycle analysis (ECA) as follows. To exclude occult ovar-
ian failure, we measured serum follicle stimulating hormone (FSH) on cycle
day 1, 2, or 313. From day 8 onwards: estradiol, LH and progesterone were
measured and vaginal ultrasound examination of the ovaries was performed
every other day until the mean diameter (mean of the largest diameter and the
diameter perpendicular to the first in one plane) reached 13 mm.  Subse-
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quently, daily measurements of the same parameters followed, until ovulation
was observed. Transvaginal ultrasound examination was performed with the
use of an Aloka SSD-620 (Aloka Co., Ltd., Mitaba-Shi, Tokyo, Japan) or Toshiba
SSH-140 A (Nasu-Works, Nasu, Japan) real-time sector scanner, employing a 5
mHz transducer, calibrated at a sound velocity of 1510 m. Ovulation was
defined as disappearance of the leading follicle or diminishing of its mean
diameter by at least 60%7 . If no ovulation was apparent, daily measurements
were continued until at least 72 h after the LH peak value was obtained. The
patients were then asked to have blood samples taken for estradiol and pro-
gesterone measurement with 2-3-day intervals until menstruation.
Hormone determinations were made as follows. LH was measured with a
commercial radio-immunoassay (RIA) kit from Diagnostic Products Corpora-
tion (Los Angeles, USA). Interassay variability was 7.8% at a level of 25 IU/L.
FSH was measured using the Enzymun-FSH test from Boehringer Mannheim
GmbH, Diagnostica, Mannheim, Germany. Interassay variability was 3.7% at a
level of 8.1 IU/L. Prolactin was measured using the Enzymun-Prolactin test
(Boehringer Mannheim). Interassay variability was 5.1% at a level of 0,51 IU/
L. Progesterone was measured using the Enzymun-Progesterone test (Boehringer
Mannheim). Interassay variability was 2.5% at a level of 26 nmol/l. Estradiol
was measured using the Coat-a-Count kit of Diagnostic Products Corporation.
Interassay variability was 8.5% at a level of 976 pmol/l.
For statistical analysis we used the Mann-Whitney U test. Data are given as
mean – SEM. A P-value of < 0.05 was considered significant.
To calculate the proportion of all patients who had two cycles in which the
progesterone level remained relatively low, the frequency was counted in two
sample periods of six weeks (a 12-week period in total).
Results
In the sample period of 12 weeks, 15 of 171 patients were identified whose
progesterone values remained below the threshold of 32 nmol/l in two cycles,
yielding a proportion of 8.8%. Fifty patients who met these criteria were in-
cluded in the study. The patient characteristics are summarized in Table 2. In
all patients except one, prolactin levels were found to be in the normal range
(median 0.28, range 0.12 - 0.66; reference value <0.60 U/l). In all cycles, early
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follicular FSH level was within the reference values of our laboratory (3-15 IU/
l) with a median value of 5 IU/l and a range of 3-14 IU/l.
Table 2    Patient characteristics of 36 with primary infertility and 14 with
secondary infertility
R a n g e M e d i a n M e a n
Age 20-41 30 30.4
(years)
Cycle length 24-33 28 27.7
(days)
Infertility duration 12-137 30 48
(months)
Results of the 50 ECAs performed (Table 3) showed nine cycles to be com-
pletely normal according to the criteria applied. One of these cycles appeared
to be a conception cycle. In 16 cycles ovulation occurred, but progesterone
levels remained below the threshold of 32 nmol/l. In two cycles no follicle
was seen; progesterone remained relatively low (16 and 18 nmol/l, respec-
tively) in both cycles. Eight cycles showed an LH surge when a follicle that
was too small (<17 mm at LH peak level) was observed. In all except one of
these eight cycles, the progesterone level remained below 32 nmol/l. One of
these patients conceived. She had a maximal mean follicular diameter of 13
mm and a peak progesterone level of 29 nmol/l before the hCG of the preg-
nancy could influence this value. Fourteen LUF cycles were seen. (luteinized
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Table 3   Typical features of the extended cycle analysis for 50 cycles
Progesterone levels (nmol/l)
Type of cycle Number Range Median Mean
Normal 9 32-54 34 38.5
Ovulatory, low progesterone 16 10-31 27 26.4
LUF cycle 14 13-38 20 21.1
Follicle < 17 mm at LH surge 8 9-32 23 23.6
No follicle at LH surge 2 16-18 17 17.0
No follicular growth 1 1
LUF, luteinized unruptured follicle; LH, luteinizing hormone
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Table 4.    Clinical and hormonal characteristics in ovulatory cycles (groups 1 and 2 combined), cycles with luteinized unruptured follicles (group 3)
and cycles with early onset of luteinizing hormone surge (group 4). Data are given as mean – SEM
Groups 1 and 2 Group 3 Group 4
Age (years) 31 – 1 31 – 1 27 – 1*
Mean cycle length (days) 28 – 0 27 – 1 28 – 1
FSH (IU/l) 7.6 – 0.6 7.0 – 0.8 9.5 – 1.6
LH maximum (IU/l) 60 – 6 49 – 6 48 – 10
Prolactin (U/l) 0.33 – 0.02 0.25 – 0.03* 0.28 – 0.05
Estradiol maximum (pmol/l) 856 – 40 866 – 76 657 – 111*
Progesterone  maximum (nmol/l) 31 – 2 21 – 2** 20 – 3**
FSH, follicle stimulating hormone; LH, luteinizing hormone; *, p < 0.05; **, p < 0.01
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Discussion
In the present study we demonstrated that in 50 women with maximal luteal
progesterone levels repeatedly below 32 nmol/l, only nine women (18%) had
normal cycles according to  prior criteria presented in Table 1. In 39 patients
(78%) progesterone levels did not increase above 32 nmol/l. It is doubtful, if,
notwithstanding a normal follicular growth pattern, normal ovulation and normal
hormonal events, cycles may be considered as normal when mid-luteal pro-
gesterone levels do not reach the value of 32 nmol/l. If these cycles are con-
sidered as normal, 25 of the observed 50 cycles showed definite abnormali-
ties. In 1978, Marik and Hulka14 as well as the group of Koninckx15 published
their classical work on so-called LUF cycles: anovulatory cycles in regularly
menstruating women, whose ovaries show corpus luteum formation and who
have production of progesterone in the luteal phase. Koninckx and colleagues15
suggested that LUF cycles could not be distinguished from ovulatory cycles by
unruptured follicle cycles were defined as normal follicular growth and nor-
mal hormonal events up to the moment of expected ovulation, but ovulation
being absent). The remaining cycle showed no follicle growth or luteinization
at all (progesterone < 3 nmol/l).
As the subjects in group 1 (normal cycle) and group 2 (ovulatory cycle but
progesterone below 32 nmol/l) all showed normal follicular development and
ovulation, we combined the data of these groups and compared them with
the data of groups 3 (LUF cycles) and 4 (LH surge at a mean follicular diameter
of < 17 mm) (Table 4).
In the 14 patients showing a LUF cycle, the peak plasma progesterone levels
and prolactin levels were significantly lower. In the eight patients with an LH
peak level at a follicular diameter of < 17 mm, significantly lower values of
maximal estradiol, and progesterone were found, as well as a lower age. The
significantly lower progesterone values in LUF cycles have been reported by
others6,7.
In summary, 50% of the observed cycles that were extensively analyzed showed
definite abnormalities. As in 8.8% of all referred patients two low-progester-
one cycles could be expected, an overall abnormality rate of at least 4.4%
might be found in an infertile population.
84
Chapter  4
hormonal parameters. Hamilton and co-workers6, however, described a typi-
cal pattern of follicular growth (continuing growth instead of disappearance)
in combination with a significant reduction of serum progesterone serum lev-
els in the luteal phase, as well as LH peak values lower than those seen in
control cycles. Striking were the normal follicular growth as well as hormonal
events until LH reached its peak value. Ovulation, however, did not occur, and
progesterone levels almost invariably remained below 32 nmol/l. Eissa and
co-workers7 gave the same definition for what they called cyst-like cycles and
they reserved the term LUF cycle for cycles showing no rupture but some
decrease in follicular volume after the LH surge, but with normal luteal phase
progesterone. Hamilton and co-workers9 observed 10 of 14 (71%) LUF cycles
where progesterone did not reach 32 nmol/l, in contrast to no more than 10 of
127 (7.9%) abnormal cycles when progesterone was 32 nmol/l or more.
Several other more-or-less overlapping patterns of abnormal follicular growth
have been described, indicating that there seems to be no typical feature, LUF
being only one possibility10,16-20. Moreover, by studying subsequent cycles in
the same individual, different patterns may be seen7 , suggesting that the
continuation of abnormal follicular growth is more important than the typical
abnormalities observed.
It is not yet clear whether these cycles are associated with reduced fertility, or
whether there is a causal relationship. Eissa and associates7, however, found
58% abnormal cycles in an infertile group, compared with 23% in a donor
insemination group (p  < 0.005). Their group7 and that of Hamilton9 did not see
any pregnancy in LUF cycles.
To be of significance for fertility, these abnormal cycles must occur in at least
a substantial part of the cycles. The importance of these subtle ovulation dis-
orders for fertility therefore remains questionable. Etiologic factors being un-
known, there is no firm basis for any kind of treatment. Our preliminary
results indicate that cycles are not always normalized, in spite of normalized
blood progesterone levels, with current ovulation-inducing treatments. We
found persisting LUF cycles in two patients treated with anti-estrogens in spite
of mid-luteal progesterone levels of 37 and 39 nmol/l. Another patient showed
the same phenomenon during treatment with gonadotropins (human meno-
pausal gonadotropin and hCG). Progesterone levels reached a value of 32
nmol/l.
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Abstract
Serial monitoring by plasma progesterone measurement is advised in the lit-
erature for fertility work-up, to detect ovulation disturbances in women pre-
senting with regular menstrual cycles. Three strategies to diagnose such sub-
tle ovulation disorders (SOD, defined as anovulation, inadequately timed ovu-
lation or ovulation of a follicle of reduced size in regularly cycling women)
were evaluated, in order to investigate costs of such a diagnosis. On the basis
of a maximal, an ultrasound-only, and a preselection strategy, total medical
costs and costs including non-medical costs were calculated for each SOD
diagnosis. A maximal diagnostic strategy resulted in a total medical cost of
ECU 9057 per diagnosis (including non-medical costs ECU 12 787); an ultra-
sound-only strategy in ECU 4520 ( ECU 6791) per diagnosis. By use of a
preselection strategy, 4.25% of the women were found to have an SOD, at a
cost of ECU 3036 (ECU 6868) for each diagnosis. As the real significance of
SOD diagnosis for the prognosis of the patient to become pregnant without
treatment remains unclear, and as no randomized trials on treatment effective-
ness have as yet been undertaken, it is questionable whether this approach is
worthwhile.
Introduction
In approximately 20% of couples who attend a fertility clinic, ovulation disor-
ders associated with oligo- or amenorrhea are  considered the most likely
explanation for sub- or infertility1. Regularity of the cycle, and symptoms such
as premenstrual breast swelling and  dysmenorrhea, may be indicative of an
ovulatory cycle. Recording of the basal body temperature (BBT) and proges-
terone measurements can be used for the qualitative or quantitative assess-
ment of progesterone production. The use of serial hormone estimates in
combination with ultrasound measurements has, however, shown that subtle
ovulation disorders (SOD) may exist in a proportion of women presenting
with regular menstrual cycles and a biphasic BBT2,3. Ovulation may either not
occur at all, which is the case in luteinized unruptured follicle (LUF) cycles2-5.
In these cycles a normal increase of serum estradiol concentrations is ob-
served as well as a normal increase in follicle diameter. After the luteinizing
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hormone (LH) surge, however, the follicle does not ovulate. Other instances
of a SOD are an inadequately timed ovulation6 (ovulation more than 48 h after
the LH peak value) or ovulation of a follicle of reduced size (<17 mm in
diameter)6-8. In cycles in which luteal serum progesterone concentrations re-
main relatively low, a high percentage of ovulation disorders has been de-
scribed, especially LUF cycles3,5. Progesterone levels < 32 nmol/l may also
have a predictive value for abnormalities in a subsequent cycle9. The use of
serial hormone determinations together with repeated ultrasonographic meas-
urements of follicle diameter is, however, a burden for the patient and is
expensive. To our knowledge, a cost-analysis of such a diagnostic work-up
has not been published to date.
The aim of the present study was to evaluate the costs necessary to diagnose
subtle ovulation disorders, defined as anovulation or inadequately timed ovu-
lation (ovulation of a follicle with a mean diameter < 17 mm or ovulation later
than 48 h after the LH surge) in women with a history of regular menstrual
cycles of 24 - 36 days duration. We compared costs of diagnosing a subtle
ovulation disorder between three diagnostic strategies: a most likely low-cost
preselection strategy, a maximal strategy and an ultrasound-only strategy.
Materials and methods
Description of the three diagnostic strategies
Maxima l  d ia gno s t i c  s t ra t e g y
Ideally, a diagnostic method identifies all fertility reducing factors in a particu-
lar patient group. With regard to subtle ovulation disorders this requires ex-
tensive cycle monitoring, combining hormone assays with sonographic find-
ings in a so-called extensive cycle analysis (ECA). If applied to all patients
with a regular menstrual cycle of 24 - 36 days duration, we called it the
maximal diagnostic strategy. Such a cycle analysis was carried out as follows.
After determination of serum follicle stimulating hormone (FSH) on cycle day
(CD) 1, 2 or 3, to exclude occult ovarian failure, serial ultrasound and hor-
mone assays (luteinizing hormone (LH), 17ß-estradiol and progesterone) were
performed every other day from CD 8 onwards, until a mean follicular
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diameter of 13 mm was reached. Hereafter, daily examinations were performed
until ovulation was observed, or until 3 days after the LH peak value if ovula-
tion did not occur. In the remaining part of the cycle 17ß-estradiol and proges-
terone were measured at 2-3 day intervals until menses. Hormone assays were
performed with commercially available kits, as described earlier9. We used
preset criteria, based on the literature, to consider a cycle as normal: 17ß-
estradiol rise in the late follicular phase > 400 pmol/l10; mean follicular diam-
eter > 16 mm at the LH surge6-8,11; ovulation, defined as at least 60% decrease
of mean follicular diameter, within 48 h after the LH surge2,3,6,12,13.
Ult ra sound -on l y  s t ra t e g y
With an ultrasound-only approach, abnormalities such as an LUF cycle or
ovulation of a follicle of reduced size would be seen, but hormonal events
and the relation of these to follicular dynamics would remain obscure. As the
occurrence of the LH surge as a reference point is not available, ultrasound
scans will have to be continued for several days in cycles where ovulation
does not occur at the expected time.
Pre s e l e c t i on  s t r a t e g y
We applied a third option: a preselection of patients by screening for proges-
terone serum levels in the luteal phase. This option was based on a publica-
tion by Hamilton e t  a l .5 who found half of the cycle anomalies in a small
group of women with  progesterone levels < 32 nmol/l, whereas the other half
was detected in the large group with normal progesterone. By serially measur-
ing luteal progesterone levels, we tried to identify a group of patients who
might have an increased chance to exhibit a subtle ovulation disorder in a
subsequent cycle9. This part of the study was conducted at the Department of
Reproductive Endocrinology and Fertility of the University Hospital Utrecht.
In our infertility population, all women who had a regular cycle (24-36 days)
were monitored with a basal body temperature (BBT) chart, while serum
progesterone was measured at 3 -4 day intervals during the second half of the
cycle. Progesterone was considered as normal if a level of 32 nmol/l was
obtained on at least one occasion,5,9,14. If this value was not reached in 2
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cycles, an extensive cycle analysis (ECA) was performed. Fifty women who
met these criteria were subjected to an ECA.
To calculate the proportion of all patients who had two cycles in which the
progesterone level remained < 32 nmol/l, the frequency was counted in two
sample periods of six weeks (a 12-week period in total). In this period of time,
177 couples of which the woman had regular cycles were referred to our
fertility unit.
Calculation of the costs
Costs can be divided into direct medical costs (wages for medical and labora-
tory personnel, expenses for analyser machines and reagents, additional costs
for housing, energy and maintenance), indirect medical costs (personnel for
administration and desk tasks, expenses for computers, telephone costs, hous-
ing and maintenance), and non-medical costs (costs patients have to make to
visit the hospital, loss of productivity when traveling to and staying at the
hospital). In our calculations we restricted ourselves to the costs during the
diagnostic process. Direct and indirect medical costs (total medical costs) are
given, and where appropriate an indication of total cost (total medical costs
and non-medical costs) is mentioned. The values of these costs are derived
from an investigation of real costs of diagnostic procedures in the University
Hospital Utrecht which was performed in 1991 by the Department of Admin-
istration and Information, and not from the negotiated tariffs, charged to the
patients, for laboratory and ultrasound procedures15. In this investigation the
non-medical costs were also calculated for an average Dutch population. We
must realize, however, that non-medical costs may differ greatly between coun-
tries and patient populations. In our patients, the mean time period needed
for traveling, waiting and blood withdrawal was estimated to be 84 min; for an
ultrasound examination this time period was 79 minutes. Costs for loss of
production were considered ECU 11.7/h; for each hospital visit an amount of
ECU 9.15* was calculated as costs for transportation.
*1 ECU = £0.65.
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Results
Costs as calculated for the three strategies.
The medical costs for the applied hormone assays and transvaginal ultra-
sonography are given in Table 1. The total medical costs for the three strate-
gies were calculated as described below.
Table 1 Medical costs for some hormone assays and transvaginal ultra-
sonography.
The costs are given in ECU (1 ECU = Dfl 2.23 = £ 0.65)
Dir e c t I n d i r e c t Total
In v e s t i g a t i on m e d i c a l m e d i c a l m e d i c a l
c o s t s c o s t s c o s t s
LH 5.54 5.34 10.88
FSH 4.64 5.34 9.98
17b-Estradiol 13.01 4.74 17.75
Progesterone 5.87 5.34 11.21
Ultrasound 13.83 34.20 48.03
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Maxima l  d ia gno s t i c  s t ra t e g y
A cycle of every patient should be examined in a precise way, as we did in our
selected patient group (see Pre s e l e c t i on  s t r a t e g y). In our investigation the mean
number of hospital visits for the screening of one cycle was 13, during which
seven ultrasound examinations, one FSH, seven LH, 12 17ß-estradiol and 12
progesterone measurements were performed. One hundred extended cycle
analyses (ECA) would cost (total medical costs) ECU 76 987.  In our patient
population the extra non-medical costs were ECU 31 700. Costs for each SOD
diagnosis would depend on the incidence. With the preselection approach we
found an incidence of 4.25%. On the basis of the study of Hamilton e t  a l .5 we
assumed that the incidence in the whole population is twice as high (8.5%).
Thus, it can be calculated that the total medical costs of diagnosing one SOD
would be ECU 9057 (total costs ECU 12 787).
Ult ra sound -on l y  s t ra t e g y
Using the ultrasound-only strategy in all patients, and assuming eight
ultrasounds per cycle, for 100 cycles the total medical costs would be ECU 38
424 (non-medical costs a surplus of ECU 19 300). If all disorders were to be
detected, again assuming an incidence of 8.5%, the total medical costs for one
diagnosis would be ECU 4520; the costs including non-medical costs ECU
6791.
Pre s e l e c t i on  s t r a t e g y
In the sample period of 12 weeks, 177 women with regular cycles were eligi-
ble for screening for luteal progesterone. Progesterone serum values were =
32 nmol/l in 145 women (82%) and < 32 nmol/l in 32 (18%). Progesterone
measurements were not repeated In eight patients because of severe sperm
abnormalities, tubal disease or because the patient was unable to attend the
outpatient clinic regularly. In 24 patients, progesterone measurements were
repeated in a subsequent cycle. In nine of these, a progesterone value of > 32
nmol/l was found (5% of the initial patients), while in 15 patients (8.5%) the
progesterone level was again < 32 nmol/l. In an earlier study9, we performed
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Women with
regular cycles
100%
(n = 177)
serial
progesterone
measurements
normal
82%
too low*
18%
second cycle
progesterone
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normal
5%
not repeated
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too low
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4.25%
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Figure 1.  Combined results of serial luteal phase progesterone measurements in 177 patients, and extensive analysis of a cycle
in 50 patients. *Defined as all progesterone concentrations < 32 nmol/l when measured at 3-4-day intervals in the second half
of a cycle. In 50 cycles, preselected in the same way, a 50% incidence of subtle ovulation disorders was found
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 Discussion
Monitoring of plasma progesterone is generally advised for fertility work-up
to detect ovulation disturbances in women presenting with regular menstrual
cycles. Reported minimal progesterone levels to confirm ovulation range from
9.6 to 32 nmol/l. Andrews16 mentions a lower limit of 9.6 nmol/l, Glass17 9.6-
12.8 nmol/l, Greenspan18 12.8 nmol/l, Rowe e t  a l.19 18 nmol/l, and Speroff20 21
nmol/l, preferably 32 nmol/l. In the recently published guidelines of the ESHRE
Capri Workshops21, progesterone concentrations > 16 nmol/l for a minimum
of 5 days are suggested as indicative for ovulation. This recommendation is
based on one report  by Landgren e t  a l .22. In this investigation of 68 normally
menstruating women, 94% appeared to have blood serum progesterone con-
centrations > 16 nmol/l for at least 5 days. The above-mentioned cut-off values
were chosen as the authors arbitrarily expected 95% of all women to have
ovulatory cycles. The ESHRE Group21 advocates the measurement of proges-
terone as the most cost-effective compromise in diagnosing anovulation, an
an extensive cycle analysis in 50 patients who had had a low-progesterone
cycle twice before. We found a subtle ovulation disorder in 50%. The com-
bined results of the above mentioned observations are summarized in Figure
1. Numbers are given as the percentages of the initial number of individuals (n
= 177).
For calculation of the costs, we started with an imaginary cohort of 100  pa-
tients. The mean number of visits needed to perform the serial progesterone
measurements was five. In the extensive cycle analysis, the mean numbers of
the various assays and investigations have been mentioned above. The finan-
cial costs were calculated on the basis of the foregoing assumptions. Of the
initial 100 serial progesterone determinations, 13.5 had to be repeated. The
total medical costs for these prescreening cycles would be ECU 6362. Exten-
sive cycle analysis would have been done 8.5 times at a total medical cost of
ECU 6544. For the 100 referred patients costs would be ECU 12 906 (non-
medical costs ECU 18 000 extra). In this group of patients a number of 4.25
subtle ovulation disorders are expected. This implies that the total medical
costs of diagnosing one case would be about ECU 3036 (total costs ECU 6868).
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ideal method being absent. In the above-mentioned publications, no refer-
ences to any published results of research are given, except for the study of
Landgren e t  a l .22, in which their unproven hypothesis was used to determine a
progesterone level that distinguishes an ovulatory from an anovulatory cycle.
None of the publications provides guidelines as to how to confirm a diagnosis
of anovulation when too low progesterone concentrations have been found.
Also, data on recurrence of low-progesterone cycles and on the prognosis for
pregnancy without treatment23 once a low-progesterone cycle has been estab-
lished, are not given. Recommendations for treatment, if mentioned, include
the use of various drugs for ovulation induction. Although pregnancies have
been documented following such treatments4,24-28, none of these studies are
based on randomized controlled trials.
In our patient population, screening by serial progesterone measurements,
and subsequently performing an extended cycle analysis in cases where no
progesterone value was > 32 nmol/l in two cycles, resulted in a 4.25% inci-
dence of the diagnosis subtle ovulation disorder. This preselection strategy
appears to entail less than half the total medical costs of the maximal strategy
and less than the costs of the ultrasound-only strategy. By using the
preselection strategy, however, about half of the diagnoses SOD will remain
unidentified, and with the ultrasound-only strategy some cases may be missed.
With the latter strategy, no LUF cycle, an otherwise anovulatory cycle, or a
cycle in which a too small follicle ovulates, would escape attention, but other
subtle ovulation disorders, for instance delayed ovulation, cannot be diag-
nosed in this way. In the 50 cycles we observed9, 25 were abnormal. These
cycles would have been adequately diagnosed with ultrasound alone.
Although the preselection and ultrasound strategies are the least expensive
approaches, they still result in high costs for establishment of diagnosis. In our
opinion, these costs are not in balance with the possible but still unclear and
unproven advantages. Regardless of how subtle ovulation disorders are diag-
nosed, treatment strategies with proven efficacy are lacking.
Nevertheless, measuring of progesterone concentrations in the diagnostic work-
up of women who attend a fertility clinic is common practice. This indicates
that we are still largely in the era of authority-based rather than evidence-
based medicine. We make great efforts to diagnose a disorder of which we do
not know whether or not it is a repetitive phenomenon, and whether or not its
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treatment is effective.
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Abstract
Since the introduction of Clomiphene citrate (CC), more than three decades
ago, a discrepancy has been observed between ovulation and pregnancy rates
for which as yet no explanation exists. To investigate if ovulation disorders or
abnormal hormonal patterns occur more often in CC-stimulated seemingly
ovulatory cycles, we performed hormonal and sonographic monitoring in first
cycles of oligo- or amenorrheic patients who were stimulated with 50 mg CC,
and compared the hormonal patterns to these  in natural cycles of age-matched
proven fertile women.  Twenty-four first CC cycles were monitored. Twelve
cycles appeared to be ovulatory, eleven showed no follicle development and
one cycle exhibited the luteinized unruptured follicle (LUF) phenomenon.
Ten ovulatory cycles were compared with 27 unstimulated control cycles. In
four cycles stimulated by CC, a temporary decline in estradiol levels was ap-
parent. In these cycles estradiol reached a higher level on cycle day (CD) 7 or
8 compared to cycles without a decline. Such an estradiol decline was seen in
only one control cycle. Furthermore, the estradiol levels on CD 7 or 8 ap-
peared to be age-related.
We conclude that the estradiol decline in CC-stimulated ovulatory cycles may
be a consequence of a sharp rise after CC stimulation, and such a rise may be
age-related and coincide with a diminished follicle quality. If this phenom-
enon is associated with a suboptimal cycle, and so contributes to the subopti-
mal pregnancy rates after ovulation induction treatment with clomiphene citrate,
is still unknown.
Introduction
Clomiphene citrate (CC) has been used since 1967 to induce ovulation in
patients with oligo- or amenorrhea who wish to become pregnant. It is gener-
ally accepted as the first-line drug in normogonadotropic patients including
patients with the polycystic ovary syndrome (PCOS). The mechanisms of ac-
tion of CC are not fully understood1,2. CC is able to occupy estrogen receptors
for a prolonged period of time and it has agonistic as well as antagonistic
properties. CC is thought to act mainly by (partially) blocking the negative
feedback of 17ß-estradiol in the hypothalamic-pituitary axis. CC administra-
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tion is followed by a rise in serum concentrations of both luteinizing hormone
(LH) and follicle-stimulating hormone (FSH)3,4, subsequently stimulating
follicular growth.
A concern regarding CC treatment is the discrepancy between ovulation rates
and pregnancy rates. Of normogonadotropic and PCOS patients 57-91% will
ovulate as judged by a biphasic basal body temperature (BBT) record, a pro-
gesterone rise or a secretory endometrium, but only 25-43% become preg-
nant5-7. Several factors have been implicated for this discrepancy including
other causes for the infertility, endometrium receptivity, corpus luteum func-
tion, early embryo quality and cervical mucus6. Little is known about disorders
of follicle growth and ovulation in patients treated by CC for anovulation or
oligo-ovulation. Hamilton e t  a l.8 observed six luteinized unruptured follicle
(LUF) cycles in 45 CC-stimulated cycles. In studies comparing hormonal pat-
terns in CC cycles and spontaneous cycles, no reasons for concern have been
found3,4,9. However, except for the very first studies, results are given as mean
values of groups of patients and not of individual patients. In two studies3,10
where individual hormone patterns are shown, a temporary decline of serum
estradiol levels can be seen. No attention to this phenomenon has been paid.
To investigate if ovulation disorders like LUF cycles, or abnormal hormonal
patterns occur more often in CC-stimulated seemingly ovulatory cycles, we
performed hormonal and sonographic monitoring in first cycles of oligo- or
amenorrheic patients who were stimulated with 50 mg CC. We compared the
hormonal patterns with these  in natural cycles of age-matched proven fertile
women.
Subjects and study design
The study was conducted at the Department of Reproductive Endocrinology
and Fertility of the University Hospital Utrecht. From august 1995 we offered
all patients who were treated with CC, hormonal and ultrasonographic moni-
toring of the first cycle. The reason for this was the uncertainty regarding the
discrepancy of ovulation and pregnancy rates as mentioned before. Ovulation
disorders such as LUF cycles, or abnormal hormonal patterns could be re-
sponsible for this problem. We felt that monitoring of the first cycle might
guard patients for several months of inadequate treatment.
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Twenty-four patients (age 22-33 years), treated from August 1995 until July
1996 were included in the present study. Five of them were amenorrheic, 18
patients had oligomenorrhea (mean cycle length > 6 weeks) and in one pa-
tient with otherwise unexplained infertility a LUF cycle had been observed.
Fourteen patients were diagnosed as PCOS on the basis of an elevated (> 10
IU/l) serum LH and/or elevated testosterone (>2.0 nmol/l) or androstenedione
(>7.0 µmol/l) concentrations. Six patients had a normogonadotropic and normo-
estrogenic hormonal status and three patients had a normogonadotropic and
hypo-estrogenic amenorrhea. The latter group of patients is always offered a
try-out treatment with CC in our department.
The control group consisted of 27 healthy volunteers in the same age group
(22-33 years), who took part in a large study on the effects of age on ovarian
function. Volunteers were enrolled in the study protocol if they met all of the
following criteria: (a) regular menstrual cycles with a length between 23 and
35 days, (b) biphasic BBT, (c) proven natural fertility by having had at least
one pregnancy, (d) each of the pregnancies had to be established within one
year of exposition, (e) no evidence of any endocrinological disease, (f) no
history of ovarian surgery, (g) no ovarian abnormalities as assessed by vaginal
ultrasound, (h) interruption of hormonal contraception at least 2 months be-
fore entering the study protocol, (i) written informed consent given.
Ovulation induction and monitoring
The patients were treated with 50 mg CC on the third to seventh day after the
start of a spontaneous or a progestogen-induced vaginal bleeding. Monitoring
consisted of repeated serum estradiol, FSH, LH and progesterone measure-
ments, and ovarian ultrasonography. Only the first induction cycle of each
patient was used for evaluation. One cycle of each control woman was used
for comparison. The same parameters were used.
Hormone assays were performed with commercially available kits. Estradiol
concentrations were assayed with a MEIA from Abbott Laboratories (Abbott
Park, IL, USA) which was performed on the semiautomated IMx analyzer.
Between-run coefficients of variation were respectively 10.1; 7.0 and 6.9% at
533; 1354 and 4197 pmol/l (n=49, 49 and 30). Serum concentrations of FSH
were measured by the Enzymun-FSH test (Boehringer Mannheim, Mannheim,
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Germany) on the automated immunoanalyser ES-600. This assay is calibrated
against the WHO Second International Reference Preparation for human FSH
(83/575). The observed interassay coefficients of variation (CV) were 3.7; 2.3
and 2.7% respectively at 8.1; 22 and 75 IU/L (n=27). For LH a similar test was
used, calibrated against the second IRP 80/552. For LH interassay coefficients
of variation of 2.4% at 6.1 U/l; 5.1% at 11.5 U/l and 6.7% at 23.2 U/l were
found (n=17). For ultrasound a Toshiba SSH-140 A or a Toshiba Capacee
(Nasu-Works, Nasu, Japan) real-time sector scanner was used, employing a 5-
mHz transvaginal transducer, calibrated at a sound velocity of 1510 m/s. Of
the follicles = 8 mm, the largest diameter and the diameter perpendicular to
this one were measured. From these two diameters, the mean diameter was
calculated and considered as the mean follicular diameter.
Monitoring was carried out on cycle day (CD) 3, 7 and thereafter every other
day until the largest follicle measured 14 mm. Subsequently, the patients were
seen daily until ovulation had occurred (total collapse of the follicle or partial
collapse by 50% or more compared to the previous  mean diameter11) or until
3 days after the peak LH value. The control women were investigated on CD
1, 2 or 3, thereafter on CD 5, 6 or 7 and subsequently, every other day and in
the same way as the patients.
Methods of analysis
Results of hormone assays are influenced by the interassay variation of the
used method and by within-subject biological variation of hormone levels.
Because we wanted to analyze hormone patterns of individual patients, the
so-called critical difference between hormone levels at different times was
calculated. For this purpose we applied the following formula12:
CD = Z x /2 x /(CV
A
2 + CV
I
2)
where CD is expressed as a percentage; CV
A
 is the analytical imprecision, CV
I
is the average inherent within-subject biological variation, and Z is the Z-score
which depends on the probability selected for the statistical significance. At
the 0.95 confidence level, Z = 1.96. In our calculation we used 1.96 for Z; 10%
for CV
A
 
 (interassay coefficient of variance of the assay), and considering the
patients their own control 0% for CV
I
. A difference of > 27.4% resulted as a
difference at the 95% level, so estradiol concentrations were considered to be
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declined compared to a previous one, if the difference between the two val-
ues exceeded 27.4%.
Data were analysed using SPSS (version 6.4, for Windows): Fishers Exact Test
for comparison of proportions, the Mann-Whitney U Test for comparison of
groups of samples, and correlation tests. A probability of < 0.05 was regarded
as significant.
Results
Twenty-four patient cycles and 27 control cycles were monitored. Twelve of
the CC-induced cycles appeared to be ovulatory, eleven showed no follicular
development nor estradiol rise, and one LUF cycle was seen. PCOS patients
more often had an anovulatory cycle (9 out of 13) than patients with other
diagnoses (2 out of 10; P=0.04, Fishers Exact Test). The mean age (– SD) of all
CC-treated patients was 27.8 – 3.6 years. The patients with an ovulatory cycle
were 28.3 – 3.6, and the patients with an anovulatory cycle were 27.7 – 3.3
years old. The patient who had a LUF cycle was 22 years old. The mean age of
the volunteer women was 29.1 – 2.8 years (differences non-significant).
The patterns of follicle growth and the concentrations of estradiol, FSH and
LH in the 12 ovulatory CC cycles were compared with those in ovulatory
cycles of the 27 volunteer women. In line with data reported in the literature,
mean estradiol concentrations were higher during the midfollicular phase in
the CC-stimulated cycles, as were FSH and LH (results not shown). The mean
follicle diameters were not different in CC compared with control cycles.
Mean or median values of pooled cycles, however, do not give information
about hormone levels or follicle growth i n  i nd i v i dua l  pa t i en t s. Therefore we
studied the patterns of the estradiol concentrations in the follicular phase of
individual cycles in detail, and we compared them with those in ovulatory
cycles of the 27 volunteer women. In two CC cycles this was not possible
because both on CD 7 and CD 8 no blood test results were available.
Of the ten evaluable ovulatory cycles after 50 mg of CC per day during CD 3-
7, four showed a temporary decline of serum estradiol concentrations be-
tween CD 7 and 11 by more than 27.4% (the critical difference);  in three
other cycles a decline also occurred, however, by 10.9%, 20.5% and 22.1%
respectively. In Figure 1, the estradiol levels of each of the four cycles express
109
Hormone  pa t t e rn s  a f t e r  c l om iph en e  c i t r a t e
 7 8 9 10 11 12 13  
Day of the cycle
0
200
400
600
800
1000
1200
1400
1600
1800
2000
E
st
ra
d
io
l 
p
m
o
l/
l
ing a decrease >27.4% are shown. The mean magnitude of the decline was
44.6% (range 28.8-64.5%). After this decline, the estradiol levels showed a
continuous rise until the start of the pre-ovulatory LH surge. In three of these
cycles the follicles showed a steady increase in size, in one the mean follicle
diameter remained 14 mm during CD 6-10: thereafter, it increased to 26 mm
before ovulation. The duration of the follicular phase, the growth rate of the
follicles, and the maximally reached follicular diameters before ovulation were
not different between the two groups.
Of 27 control cycles, a decline in estradiol concentration was only observed in
one cycle. In this cycle, a follicle was observed on CD 9, that reached a
diameter of 13 mm and disappeared after CD 12, on which day another follicle
took over. The estradiol level fell by 36.4%.
Summarizing in 4 of 10 CC-stimulated cycles, an estradiol decline of > 27.4%
occurred, as compared to 1 of 27 unstimulated control cycles (p  = 0.01, Fish-
ers Exact Test; odds ratio 17.3 with 95% confidence interval 1.6-184.4).
Figure 1. Serum estradiol concentrations in the follicular phase of four
cycles expressing a temporary decline > 27.4%
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Figure 2. Serum estradiol concentrations on cycle day 7 or 8 in clomiphene
citrate-stimulated patients. Group 1 with estradiol decline > 27.4%; group 2
without decline. Median values are indicated
To compare estradiol concentrations between the two groups of CC-stimu-
lated cycles (with or without estradiol decline) and the control cycles, estradiol
levels of 2 consecutive days were clustered because the patients as well as the
control women were seen on alternate days. If estradiol was determined on
both days, the mean of the two concentrations was used. estradiol concentra-
tions on CD 7-8 are shown in Figure 2. As expected, estradiol concentrations
were higher in the whole group of CC cycles compared to control cycles (p  <
0.01; result not shown in the figure). In the four cycles in which estradiol
declined beyond the critical difference, estradiol was higher than in cycles
that showed no such decline (p  = 0.05) (see Figure 2). Similar trends were
seen for FSH concentrations (p  < 0.01 for cycles with, and p  = 0.14 for cycles
without significant estradiol decline  respectively).
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To investigate if higher estradiol concentrations on CD 7-8 correlated with
age, these parameters were plotted against each other (Figure 3). A positive
correlation was observed between age and estradiol level in the 10 CC-treated
cycles (Pearsons r  = 0.67; p  < 0.05). Similar correlations were found within
both subgroups. The m a x i m u m estradiol concentration that was reached in
each of the CC-stimulated cycles was also plotted against age; no correlation
appeared to be present. FSH concentrations on CD 7-8 did not appear to be
related to age. In the control group non-stimulated estradiol levels did not
appear to be correlated with age (data not shown).
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Figure 3. Relation of serum estradiol on cycle day 7 or 8 to age in ten
clomiphene citrate-stimulated patients. Group 1 with estradiol decline
> 27.4% (<), group 2 without estradiol decline (O).For the total population,
r  = 0.67 and p  < 0.05
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Discussion
In 24 first CC-stimulated cycles, 12 appeared to be ovulatory, 11 anovulatory,
whereas 1 LUF cycle was seen. A 50% ovulation rate in a first CC cycle is in
agreement with literature data13. Ovulation disorders such as LUF (1 out of 24
cycles) can not be considered as an explanation for the reported discrepancy
between the ovulation rate and the pregnancy rate in CC cycles. In the follicular
phase of ovulatory CC-stimulated cycles a temporary decline in estradiol lev-
els apparently often occurs, in contrast to natural cycles (4 out of 10 cycles,
compared to 1 out of 27 unstimulated control cycles). This phenomenon has
previously been shown, but its significance has not been subject of discussion.
This decline may be explained by a high response of estradiol production
during  the CC exposure. In the four cycles with an estradiol decline, the
estradiol concentrations were indeed higher on CD 7-8 compared with cycles
without a decline and control cycles. The same trend was observed for FSH.
There appeared to be a positive correlation of estradiol levels and age.
These observations might be explained by the findings of Hughes e t  a l.14.
They  examined  se rum inh ib in  and  e s t r ad io l  r e sponses  to  ova r i an
hyperstimulation for i n  v i t r o fertilization. Inhibin responses were significantly
lower in women 35 years of age or older. Estradiol responses were not influ-
enced by age. This suggests that the two hormones reflect different granulosa
cell functions, and that a diminished inhibin response to ovarian stimulation
may be a marker of declining granulosa cell function with age. In other words:
as the ovarian depletion of follicles progresses, the production of inhibin is
impaired; however, the production of estradiol is not yet impaired at an early
stage of follicle depletion.
If we apply the findings of Hughes e t  a l. to our patients, we come to the
following hypothesis: After the production and release of FSH is increased by
the action of CC, the negative feed back by inhibin towards the central system
is subnormal in the older patients. As a result the FSH concentrations rise to a
higher level. This higher concentration of FSH stimulates the estradiol produc-
tion of the cohort of follicles that had been recruited at that moment. The rise
of estradiol prevents the FSH levels from rising above the normal range by
activating estradiol dependent negative feed back mechanisms. The net result
is a higher estradiol level at the end of the stimulation by CC, on CD 7-8.
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Hereafter, the selection of a dominant follicle takes place and the estradiol
levels at the end of the follicular phase no longer reflect an age-dependancy.
The significance of these phenomena for the quality of the cycle, however,
remains unknown, and there is as yet no proof to suggest that they indicate
suboptimal follicle growth, and so contribute to the discrepancy between the
ovulation rate and the pregnancy rate in patients using CC for ovulation in-
duction. We conclude that the often occurring temporary decline of estradiol
at the midfollicular phase is an age-dependent phenomenon.
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Abstract
BACKGROUND: The cause of declining fertility with age, in women who still
have regular menstrual cycles, is not clear. METHODS: We evaluated follicle
development, endometrial growth and hormonal patterns in cycles of older
women (age 41-46 years, n = 26) who were normally fertile in the past, and
compared these cycles with a reference group of relatively young fertile women
(age 22-34 years, n = 35). RESULTS: Clearly abnormal cycles were found in
only two women in the older age group, compared to one in the younger
group. The main differences between the age groups were a shorter follicular
phase and cycle length in the older group, in combination with higher FSH
levels in the late luteal and early follicular phase. In contrast to literature data
which suggest an accelerated follicle development in older women, we found
sonographical and hormonal evidence of an advanced follicle growth, with
an earlier start already during the luteal phase of the preceding cycle, and an
advanced selection and ovulation of the dominant follicle. CONCLUSIONS:
Such an earlier start of follicle growth in a possibly less favourable hormonal
environment, as well as a limited oocyte pool, may contribute to a decreased
follicle and oocyte quality, resulting in diminished fertility in aging women.
Introduction
On average, female fertility declines from age 30 onwards (van Noord-Zaadstra
e t  a l .,1991) or even earlier (Leridon, 1977). In so-called natural breeding
populations when no contraceptive measures are used, the end of fertility is
reached at a median age of 40-41 years (Bongaarts, 1982; Wood, 1989). Menstrual
cycles, however, continue to be remarkably regular until a mean age of 45-46
(Treloar, 1981) and it takes another 5 years before menopause is reached (den
Tonkelaar e t  a l ., 1998). Postponement of childbearing, which is a demographic
trend in all Western countries, considerably contributes to the increasing
proportion of subfertile couples (Mosher and Bachrach, 1996). The cause of
declining fertility in elderly women who still have regular menstrual cycles, is
not clear. Possible explanations include a higher incidence of subtle cycle
disorders such as anovulatory or luteinized unruptured follicle (LUF) cycles,
hormonal changes, diminished uterine receptivity, or an oocyte factor. Age-
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dependent hormonal changes have been described by several authors. The
earliest endocrine change associated with reproductive aging is a selective rise
of FSH in the early follicular phase from age 35-40 onwards (Sherman e t  a l .,
1976; Reyes e t  a l ., 1977; Musey e t  a l ., 1987; Lee e t  a l ., 1988; Fitzgerald e t  a l .,
1994; Klein e t  a l ., 1996a). A rise of LH also occurs, but 5-10 years later (Ahmed
Ebbiari e t  a l .,1994). The available data about estradiol and progesterone do
not show a consistent pattern. It has been suggested that the rise of FSH is
primarily caused by a decreased secretion of ovarian inhibin. Klein e t  a l. (1996b)
showed a negative association between FSH and inhibin B in the early follicular
phase, but could not demonstrate such an association for inhibin A. A probable
explanation is that inhibin A is synthesized by the dominant follicle and the
corpus luteum, whereas inhibin B is secreted by granulosa cells of developing
antral follicles. Evidence is accumulating that a selective rise of FSH is due to
diminished negative feedback by inhibin B during the early follicular phase
(Groome e t  a l ., 1996; Klein e t  a l ., 1996b) and by inhibin A during the preceding
luteal phase of the cycle (Reame e t  a l ., 1998; Danforth e t  a l ., 1998; Welt e t  a l .,
1999; Santoro e t  a l ., 1999), acting in a tandem fashion to restrain FSH secretion
(Santoro e t  a l .,1999).
Although much is known about hormonal patterns and follicle development
in the normal menstrual cycle, it is difficult to define cycle abnormalities unless
there is no follicle growth at all or no ovulation. In the present study we used
observations in young and fertile women as a reference of cycle normality. We
considered the cycles of these women as normal, unless definite abnormalities
would be seen such as absence of follicle development or ovulation.
The aims of the present study are:
1. To obtain reference values for cycle normality from a group of relatively
young fertile women who have regular menstrual cycles.
2. To evaluate whether follicle growth, ovulation, hormonal patterns and
endometrial development in older women differ from this reference group,
and, if present, whether such differences may explain the age-related
loss of fertility.
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Materials and methods
Sub j e c t s
The study was conducted at the department of Reproductive Endocrinology
and Fertility of the University Medical Center Utrecht. It was approved by the
local ethics committee, and written informed consent was obtained from all
participants. Healthy women (aged 22-46 years) were recruited by advertisement
in local newspapers. Volunteers were enrolled in the study if they met the
following criteria: (1) regular menstrual cycles varying from 21 to 35 days, (2)
biphasic basal body temperature (BBT), (3) proven natural fertility by having
had at least one pregnancy, (4) each of the pregnancies had to be established
within one year after discontinuing contraception, (5) no evidence of
endocrinological disease, (6) no history of ovarian surgery, (7) no ovarian
abnormalities as assessed by vaginal ultrasound, and (8) cessation of hormonal
contraception at least 2 months before entering the study protocol. The
volunteers received monetary compensation for study participation.
Exper imen ta l  d e s i gn
A relatively older group of women who were normally fertile in the past (n =
26, age 41-46 years), was compared to younger women, the reference group
(n = 35, age 22-34 years). The investigations started in the midluteal phase of
the first study cycle. The luteal phase was assumed to have started when a
temperature rise on the BBT chart had been observed. The temperature was
considered to be elevated if it was higher than the temperature on any of the
six preceding days (World Health Organization, 1967). From the seventh day
after the temperature shift, the volunteers visited our research department
every two or three days for ultrasound (US) scans in which the size and
number of all follicles 2 mm in diameter or above, were counted and measured,
and endometrial thickness was determined. Blood samples were taken at each
visit and stored for determination of follicle stimulating hormone (FSH),
luteinizing hormone (LH) and estradiol (E
2
). In the samples which were most
close to the start of the menstrual period, inhibin A and B were also determined.
After the menstruation had started in the subsequent cycle (cycle 2) the
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volunteers returned on cycle day 2, 3 or 4, for US, E
2
, FSH,LH, inhibin A and
B. Thereafter, every two or three days the same measurements except inhibin
A and B were performed. When the dominant follicle had reached a mean
diameter of at least 14 mm, US scans were performed and blood samples were
taken daily until ovulation had occurred. Ovulation was defined as a complete
disappearance of the follicle or a reduction of its mean diameter by at least 5
mm (Janssen-Caspers e t  a l ., 1986; Check e t  a l ., 1990). After ovulation an US
scan was performed in the midluteal phase. At the same time blood was taken
for measuring progesterone. The length of the follicular phase was defined as
the period of time (in days) from and including the day the menstrual period
started, until and including the last day the dominant follicle was present
before ovulation. The length of the luteal phase was considered the interval
fol lowing ovulation up to and including the day before the onset of
menstruation.
Hormon e  a s s a y s
Blood sampling and transvaginal sonography were performed on the same
days. Hormone concentrations were measured in plasma (E
2
, FSH, LH and
progesterone) and serum (inhibin A and B) specimens stored at -20o C until
processing. Estradiol concentrations were assayed with a Microparticle Enzyme
Immunoassay (MEIA) from Abbott Laboratories (Abbott Park, IL, USA) which
was performed on a semiautomated IMx analyzer. Between run coefficients of
variation for E
2
 were 10.1; 7.0 and 6.9% at 533; 1354 and 4197 pmol/l, respectively
(n=49; 49 and 30). Concentrations of FSH, LH and progesterone were measured
with the fully automated AxSYM immunoanalyzer (Abbott Laboratories)
according to the instructions of the manufacturer. All specimens of each
volunteer were analyzed in the same run. The assays are all based on the
MEIA technology. The standard of the LH assay is calibrated against the WHO
First International Reference Preparation for human LH (68/40), whereas that
of the FSH assay is referenced against the WHO Second International Reference
Preparation for human FSH (78/549). For progesterone, interassay CV was
found to be 14.1% at 3.5 nmol/l; 7.8% at 19.0 nmol/l and 9.9% at 71.2 nmol/l
respectively (n=51). For LH between run coefficients of variation were 5.5; 7.2
and 7.9% at 4.8; 39 and 83 IU/l, respectively (n=48). For FSH the between run
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CV was 6.0; 6.6 and 8% at levels of 5.0; 25 and 75 IU/l (n=46). Inhibin A and
inhibin B levels were measured using an immuno-enzymometric assay (Serotec,
Oxford, UK) (Groome e t  a l ., 1996). Intra and interassay coefficients of variation
for the inhibin A and inhibin B assay were <7.7%; <8.0% and <14.6%; <14.0%,
respectively.
Transvag ina l  US mea su r emen t s
All transvaginal US measurements were performed by the same observer (G.J.S.)
using a 7.5-MHz transvaginal probe on a Toshiba Capasee SSA-220A (Toshiba
Medical Systems Europe BV, Zoetermeer, The Netherlands). The ovary was
examined by scanning from the outer to the inner margin in longitudinal
cross-sections, as described by Pache e t  a l . (1990). All follicles were measured
and counted. Mean follicle diameters were calculated from 2 or 3 perpendicular
measurements depending on the diameter (#6 mm or above) by taking the
mean of the measurements. In the analysis of dominant follicles only follicles
with a mean diameter $10 mm were included because follicle size can vary up
to 10 mm  before the dominant follicle is identified (Pache e t  a l .,1990). Follicles
of 2-10 mm in diameter were considered as antral non-dominant follicles. By
including follicles up to 10 mm the maximal antral follicle cohort will be
represented. Pache e t  a l . (1990) found a good accuracy in an in vitro study of
small cystic structures as well as a good intra-observer reproducibility of anthral
follicle numbers, and sizes of dominant follicles in 7 patients. An inter-observer
reproducibility study was performed by Scheffer e t  a l . (2000a) in 37 volunteer
women, showing an adequate reproducability of small follicle numbers. In
earlier studies, OHerlihy e t  a l . (1980) observed a good correlation between
the calculated volume  of pre-ovulatory follicles and the volume of aspirated
follicular fluid. Endometrial thickness was expressed as the total sonographic
thickness of the two layers of the endometrium.
Methods  o f  ana l y s i s
Sonographic and hormonal observations started in the luteal phase (cycle 1),
because events in the luteal phase are likely to influence the follicular phase
of the subsequent cycle (cycle 2). To synchronize hormonal and ultrasound
121
Cyc l e  d i s t u rban c e s  and  a g e - r e l a t e d  d e c l i n e  o f  f ema l e  f e r t i l i t y
data obtained in the course of an ovarian cycle, several time-markers were
used. The time after the BBT-rise was used in cycle 1 to describe the subsequent
events of the luteal phase. The nadir before a temperature rise was considered
as day 0. The start of the menstrual period in the subsequent cycle was used to
describe the follicular phase prospectively, and the day of the LH peak (the
day the highest LH level during the LH surge was reached) to investigate the
follicular phase retrospectively. Finally, the progesterone determinations in
this cycle were timed 7 days after ovulation. Ideally, a time-marker is a well-
defined, clearly recognizable event, but any of the markers mentioned has its
drawbacks. The lack of precision of the BBT-rise as a marker of ovulation is
well known (Barrett and Marshall, 1969; Dunson e t  al . , 1999). The time point
at which a menstrual period is considered to start, is a subjective choice of the
woman, especially when there is no abrupt start of the bleeding as often is the
case. It is also uncertain whether the onset of shedding of the endometrium
corresponds with the hormonal events, or depends on endometrial factors as
well. The LH peak value can be identified by using the highest value of daily
results, as we did in the present study. However, the duration and magnitude
of the LH surge and thereby the day of the highest value, may vary. In the
luteal phase and in the first half of the follicular phase, the volunteers were
seen every 2-3 days, which may result in missing values on several days in
graphical presentations of data. For that reason, in some parts of the cycles,
data of two consecutive days (and in the beginning of the second cycle of
cycle days 1-4) were pooled. If results of 2 days were available, only the value
of one of these days was used after random selection. In the tables data are
given as median values, and 10th. and 90th. percentiles; in the graphs mean
values and the 95% interval of the means (– 1.96*SEM) are displayed. Statistical
analysis was performed by using SPSS (Statistical Package for Social Sciences)
for Windows (release 10.0.7). For comparisons of results from different phases
of the cycle between age groups the Mann-Whitney U test was applied. A  P-
value < 0.05 (two-sided) and < 0.01 were considered statistically significant
and highly significant, respectively.
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Results
The group of volunteers consisted of 61 women: 35 in the reference group
(22-34 years; median age 31 years); 26 in the group aged 41-46 years (median
age 42 years). The body mass index (BMI; body weight/height2) was the same
in both groups (median value in both groups 22.7 kg/m2; P = 0.65). There was
no statistical difference in smoking habits between the groups. Mean pack-
years of smokers and past-smokers in the older group were 9.2 compared to
7.8 in the younger group (P = 0.16). After correction for age, i.e. calculating
from the beginning of smoking until the median age of the younger group,
results were 5.9 years in the older group and 7.3 years in the younger group,
respectively (P = 0.47). Among the 35 younger women the results of hormonal
determinations and ultrasound of cycle 2 were incomplete in one woman.
This cycle must have been ovulatory because she became pregnant. In the
younger group one cycle (2.9%) was judged as abnormal having a cycle length
of 16 days and a luteal phase of only 4 days. In the older group 2 abnormal
cycles (7.7%) were observed, both showing a persisting follicle. The proportion
of abnormal cycles in both groups is not statistically different (P = 0.57). The
conception cycle with missing data, and the 3 cycles that were considered as
abnormal, were excluded from further analysis. The remaining 33 cycles in
the younger age group and 24 cycles in the older age group were considered
normal ovulatory. A dominant follicle (>10 mm in diameter) was recognized,
which showed a constant growth of approximately 1.6 mm per day, and reached
a mean diameter of 15.7 to 26.4 mm before ovulation. In the follicular phases
of these cycles, there was a steady increase in E
2
 concentrations. In one cycle
no LH surge was observed. In this cycle of a 42 years old volunteer high levels
of FSH and LH were present in the follicular phase. In the luteal phase
progesterone levels rose to a normal level of 68 nmol/l. We had no good
reason to consider this cycle as abnormal. The data of 33 cycles in the younger
and 24 cycles in the older age groups are thus compared in the following
sections.
In table I, values of sonographic events and hormonal levels on relevant days
of cycles 1 and 2 of both age groups are presented. On the whole, the results
in the older group are remarkably similar to those in the reference group of
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young women. All women in the elderly group did ovulate, although the
mean diameter of the dominant follicle just before ovulation was almost 2 mm
smaller as compared to that in the women of the reference group. Some of the
differences found were in line with observations from the literature, including
the shorter duration of the follicular phase, the elevated early follicular FSH,
and a trend to decreased inhibin B levels in the early follicular phase of the
older age group. The difference of 2 days at the first appearance of the dominant
follicle is in line with the shorter follicular phase in the older women. In the
early follicular phase a much lower number of small antral follicles (2-10 mm)
was observed in the older group, without a difference in their mean volume.
The lower LH peak level in the older group has not been described previously.
In both age-groups, inhibin B levels showed an increase after the LH peak.
Progesterone levels in the luteal phase and endometrial thickness did not
differ at all or were even slightly higher in the elderly group.
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Table I. Comparison of cycle characteristics, sonographic events and hormonal levels on relevant days
of the cycles; median values (10th. - 90th. percentiles)
Age groups 22-34 years, n = 33 41-46 years, n = 24 P-value
Total cycle length (days) 28 (26 - 33) 26 (23  30) 0.001
Length of follicular phase 16 (13 - 20) 12 (10 - 15) 0.000
Length of luteal phase 13 (9 - 15) 14 (12 - 16) 0.048
Cycle day of first observation of the
dominant follicle
10 (7 - 14) 8 (5 - 10) 0.000
Diameter of the dominant follicle just
before ovulation (mm)
21.5 (17.3 - 25.2) 19,6 (17 - 24.2) 0.011
Late luteal phase inhibin A (pg/ml) 9 (2  24) 6.5 (2.6 - 16.4) 0.15
Late luteal phase inhibin B (pg/ml) 20 (9 - 97) 16 (4 - 36.8) 0.14
Late luteal phase FSH (IU/l) 4.2 (1.9 - 6.3) 5.6 (3.4 - 9.6) 0.002
Highest level of FSH during the late
luteal and early follicular phase
7.5 (5.7 - 12.1) 9.7 (7.5 - 22.6) 0.000
Early follicular antral follicle count
(AFC) (number)
10 (5.4 - 25.6) 4 (2 - 9) 0.000
Early follicular mean antral follicle
volume (mm3)
45 (23.3 - 89.2) 51.9 (26 - 122.4) 0.55
Early follicular E2 (pmol/l) 172 (100 - 277) 198 (108 - 337) 0.32
Early follicular FSH 6.1 (4.7 - 11.9) 9.6 (7.4 - 18.1) 0.000
Early follicular LH (IU/l) 3.7 (1.6 - 7.3) 4.9 (2 - 7.3) 0.09
Early follicular inhibin A 5 (1.4 - 8.6) 4 (1.5 - 9.5) 0.459
Early follicular inhibin B 87 (30 - 178.2) 54.5 (10 - 133) 0.084
Highest level of E2 1472 (1113 - 2353) 1454 (813 - 2033) 0.26
Highest level of FSH during the LH
surge
14.6 (9 - 19.2) 14.6 (8.9 - 25.1) 0.382
Highest level of LH 59.5 (25.7 - 94.8) 45.7 (25.1- 74.1) 0.046
Inhibin B on day of LH peak (pg/ml) 84 (58.8 - 256.2) 73 (28 - 127.6) 0.014
Inhibin B on day after LH peak 170 (50.6 - 304.4) 92 (31.2 - 167) 0.003
Endometrial thickness on day of LH
peak (mm)
8.9 (6.8 - 12.6) 9.1 (7.6 - 12.1) 0.966
Endometrial thickness 6-8 days after
ovulation
10.2 (7.8 - 13.8) 11 (7.6 - 13.5) 0.345
Progesterone 6-8 days after ovulation
(nmol/l)
50.7 (34.3 - 90.8) 69.9 (25.8 - 138) 0.08
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In Figure 1, several hormone values, and diameters of small antral and dominant
follicles are presented in relation to the three time-markers as defined. Results
of the luteal phase in the first cycle are displayed in relation to the rise of the
BBT, results of the follicular phase in the second cycle are plotted from the
start of the menstrual period as well as in retrospect from the day of the LH
peak level in order to correct for the observed difference in the length in the
follicular phases between the two age-groups.
The dominant follicle can be observed from cycle day 8 in the older, and day
10 in the younger age-group. On the corresponding days of the cycle (Figure
1, 1B), the mean follicle diameter in the older group exceeds that of the
younger women, and seems to be advanced in the older group by about 2
days relative to the younger group. However, when the diameters are grouped
in relation to the LH peak (Figure 1, 1C), the development of the dominant
follicle appears to be remarkably similar except for the last 3 days when
growth in the older women slows down slightly. As a result, in the older
women the dominant follicles are 2 mm smaller, on average, on the day before
ovulation (Table I).
The evolution of the E
2
 levels is in complete agreement with the growth pattern
of the dominant follicle (Figure 1, 2B - C).
Mean FSH levels in the midluteal phase (7 days after the BBT-shift, Figure 1,
3A) show comparable, low values, rising thereafter both earlier and higher in
the older age-group. This earlier rise in FSH is also present on the combined
cycle days 1-4, followed by a rise in the younger age group (Figure 1, 3B). In
the following days all FSH levels decline, which concurs with the identification
and subsequent growth of the leading follicle, and rising E
2
 levels. The gradual
rise after CD 7-8 in the older, and after CD 12 in the younger group is caused
by the FSH surge which accompanies the LH surge, that occurs much earlier in
the older group. Related to the LH peak level as a time-marker (Figure 1, 3C),
the late luteal and early follicular FSH rises can be seen 9-10 days before the
day of the LH peak (day 0) in both groups.
LH levels do not differ between the two age-groups except for a lower peak
level during the LH surge (P<0.05) in the older group.
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Figure 1. (1A - 3C). Small
antral (2-10 mm) and domi-
nant follicle diameters (1A,
1B and 1C), estradiol con-
centrations (2A, 2B and 2C),
and FSH concentrations (3A,
3B and 3C), related to the
BBT shift in cycle one (panel
A), to the start of the men-
strual period in cycle two
(panel B), and to the LH
peak in cycle two (panel C).
Data points represent means
– 1.96 SEM.
O ,  22-34 years  age
group.
              , 41-46 years age
group.
*,  P<0.05.
**, P<0.01.
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Discussion
The first aim of our study was to collect data in a younger age group of fertile
women, to be used as a reference for an older group. We considered them to
have normal cycles unless definite abnormalities were encountered. In the
literature reference groups have been reported, and in some studies criteria
for normality have been defined (van Zonneveld e t  a l ., 1994). It has been
suggested that conception cycles are the gold standard for normality, however,
reports on large series are lacking. In addition, also in such ideal cycles,
hormone levels and sonographic findings vary greatly. For example, ovulation
of a follicle of 13 mm may result in a normal pregnancy (van Zonneveld e t
a l .,1994). Moreover, the occurrence of pregnancy is dependent on many female
and male factors and it is likely therefore that, on the one hand, many ideal
cycles never result in a pregnancy, e.g. because of suboptimal timing of
intercourse, whereas, on the other hand, women with suboptimal cycles may
conceive, provided all other contributing factors are perfect. The occurrence
of pregnancy is the result of a complex and multifactorial process, and it is
well possible, therefore, that the achievement of clear-cut and generally
applicable criteria of cycle normality is an impossible goal. In the present
study we considered the cycles of the younger volunteers as a reasonable
reference group because all had earlier succeeded in achieving a spontaneous
pregnancy within one year. In this group we found cycles in which the dominant
follicle ruptured at  smaller diameters (in the younger group 16.3 and 16.7
mm; in the older group 15.7 and 16.7 mm) compared to a diameter reported
in the literature as normal (17-25 mm) (OHerlihy et  al .,1980; Zegers-Hochschild
e t  a l ., 1984; Eissa e t  a l ., 1986). In some cycles the LH peak level remained
relatively low, but criteria for a normal LH surge have never been established.
Midluteal progesterone levels not always reached the normal level of 32
nmol/l or more in the younger group (Hull e t  a l .,1982, Hamilton e t  a l ., 1987;
van Zonneveld e t  a l ., 1999), and the significance of the progesterone level in
cycles that are ovulatory, is unknown.
There is convincing evidence in the literature indicating that the fertility of
women above 40 is seriously decreased (Bongaarts, 1982; Wood, 1989; Holman
e t  a l ., 2000). The second aim of our study was to search for an explanation of
this phenomenon. However, our results do not give obvious clues. The
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majority of women had seemingly normal, ovulatory cycles with normal estradiol
and progesterone levels. In addition the growth curves of the dominant folli-
cle in elderly and younger women until some days before ovulation were very
similar. The diameter of the dominant follicle before ovulation was slightly
smaller in the older women, but whether this is an indication of diminished
follicle quality is unknown.
In the older women the follicular phase of the menstrual cycle was shorter,
and in this group the dominant follicle could be identified earlier. Whether the
dominant follicle has a faster growth rate in older women (accelerated growth),
or starts earlier (advanced growth) (Thatcher and Naftolin, 1991; Klein e t  a l .,
1996a) is a matter of debate in the literature. Our data clearly support the latter
point of view because the growth pattern of the dominant follicle as well as
the rise of estradiol in the follicular phase (see Figure 1, 1B and 1C; Figure 1,
2B and 2C) in older and younger women hardly differ. In case of an accelerated
follicle growth, a steeper slope of both the graph of dominant follicle growth
and E
2
 rise would have been expected in the older group. The shift in time of
follicle development resulting in a shorter follicular phase in the older age
group might be explained by the earlier FSH rise in the luteal phase of the
preceding cycle (Figure 1, 3A and 3B). As a result a dominant follicle is selected
from the cohort of small recruitable follicles, and stimulated to further growth
several days earlier than in the younger group. This concept is shown in
Figure 2.
The earlier rise of FSH in the luteal phase of the older women may be related
to a declining production of inhibin A by the corpus luteum (Reame e t  a l .,
1998; Welt e t  a l .,1999; Danforth e t  a l .,1998; Santoro e t  a l .,1999). We could find
a rather strong negative correlation between inhibin A and FSH levels in the
late luteal phase (combining both groups, r = -0.536; P = 0.000), although the
difference between older and younger women of inhibin A levels at the late
luteal phase, did not reach statistical significance (Table I).
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Figure 2. Time-relations of progesterone (dotted line), the luteo-follicular
FSH rise (bows), the period of follicle growth (grey rectangles), ovulation (O)
and onset of menstrual periods (M) in an older (41-46 years) compared to a
younger age group (22-34 years). Arrows represent follicular development.
Straight arrows indicate growth of a dominant follicle; curved arrows indicate
regressing follicles.
Inhibin B levels showed a sharp increase on the day after the LH peak level
compared to the previous day (Table I) in the younger (P=0.006) and in the
older group (P=0.036). Such a rise has been previously described by Groome
e t  a l . (1996), and it has been suggested by Speroff e t  a l . (1999) that it is a result
of release from the ruptured follicle. However, ovulation is not a prerequisite,
as a clear rise has also been demonstrated to occur within 24h after the induction
of an artificial LH and FSH surge by a single injection of a GnRH-agonist
during the early follicular phase (Scheffer e t  a l ., 2000b).
An advanced start of a cohort of early antral follicles in older women means
Figure 2.
Younger group
M
M
M
O
O
Older group
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that this start already takes place in the presence of a still functioning corpus
luteum (Figure 2). It is possible that the environment for the development of
preantral follicles during this phase of the cycle is suboptimal. A second
mechanism which may explain the diminished follicle quality in older women
is the limited oocyte pool model, proposed by Warburton (1989). This
hypothesis assumes that the dominant follicle, selected from the cohort of
preantral follicles, is the one which benefits longest and most from the favourable
effect of FSH during the FSH window. As the number of preantral follicles
decreases (in the present study from a mean number of 10 in women below
34 years, to 4 in women between 41-46), it becomes less likely that a follicle
will be present at the beginning of the FSH window. Consequently, follicles of
older women more often are not yet quite ready or almost too late when
selected for further growth in comparison with follicles of younger women
(Figure 2). Oocytes of older women, therefore, may be more likely to undergo
non-disjunction at the first meiotic division. Moreover, assuming that follicles
of different quality appear in the FSH window, it is more likely that a high
quality follicle is selected from a cohort of 10 (younger women) than of 4
follicles (older women).
We conclude that in spite of a dramatically decreased number of recruitable
antral follicles, follicle development, hormonal events and endometrial growth
are remarkably undisturbed in older women. Apparently, a grossly decreased
number of antral follicles does not result in cycle disturbances until an average
age of 45-46 years. Because an equal endometrial thickness is present in both
age groups, a uterine factor seems unlikely. In addition, in oocyte donation
the pregnancy rates mainly depend on the age of the donor, not of the recipient
(Sauer e t  a l ., 1993). However, some decrease in uterine receptivity with age
may be present. In recipients over 40 years of age, implantation rates using
oocytes of young donors could be enhanced by applying supraphysiological
progesterone replacement (Meldrum, 1993). The obvious decrease of fertility
in aged women probably has to be mainly explained by a decrease in oocyte
quality as is reflected by an increase of chromosomal abberations in oocytes
(Brook e t  a l ., 1984; Gaulden, 1992; Eichenlaub-Ritter, 1996) and embryos
(Warburton e t  a l ., 1986; Munne e t  a l ., 1994; Holman e t  a l ., 2000) of older
women. However, as stated above, it can not be excluded that a decrease in
oocyte quality may be the result of a decreased quality of the follicle.
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There is some evidence that an advanced start of follicle development, as
shown in older women, can be manipulated. Le Nestour e t  a l . (1993) showed
in healthy volunteer women that the intercycle FSH rise can be delayed by
administering physiological amounts of estrogens. Hypothetically, in this way
in older women the recruitment of a new cohort of follicles, and the selection
of a dominant follicle, can be pushed forward from the late luteal phase of the
preceding cycle into the early follicular phase. This would result in a situation
resembling that in younger women. Whether such an approach would enhance
the quality of the cohort of follicles and of the dominant follicle emerging
from this cohort, resulting in a more fertile cycle, remains to be confirmed.
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Chapter 8
General discussion, summary, and directions for future research
This thesis discusses some diagnostic tests in subfertile women with seemingly
normal and regular menstrual cycles, and in normal but older women who
still have a regular menstrual pattern. The diagnostic tests concern sonographic
measures and hormonal patterns reflecting the presence or absence of normal
follicle development, ovulation and corpus luteum function in women with a
normal and regular cycle pattern.
Anovulatory disorders accompanied with oligo- and amenorrhoea are well
known causes of a diminished fertility in women, which can be successfully
treated (Hull e t  a l ., 1985). Much less is known about subtle disorders of follicle
growth, and about hormonal dysregulation in women who have regular men-
strual periods. Moreover, little is known about women above 40 who still have
regular menstrual cycles, while we know that their fertility is greatly reduced.
Cycle regularity implies that the complex hormonal feedback mechanisms,
that are governed by follicle growth and the development of a corpus luteum,
are intact, and that the quality of such a cycle is expected to be normal.
The general aim of this thesis was to shed some light on this paradox: is it
really true that women with regular cycles may have subtle disturbances? How
often do they occur and how can we diagnose them? Can they be considered
as an explanation of the reduced fertility, or infertility, and how can we use
this knowledge for the management of subfertile patients?
There are several reasons why diagnostic tests are performed in medicine,
including reproductive medicine (Te Velde e t  a l ., 1995).
First, a diagnosis might be important to understand the cause and the mecha-
nism of the disease according to the classical paradigm in medical thinking:
only if we know why a patient is ill, we can consider appropriate treatment. In
reproductive medicine, however, this principle is more difficult to apply be-
cause fertility and infertility are not all or nothing phenomena, like health
and disease. Whether or not a woman will conceive within a certain period of
time, is determined by the monthly probability of pregnancy, which depends
141
Gene ra l  d i s c u s s i on ,  s ummar y ,  and  d i r e c t i o n s  f o r  f u t u r e  r e s e a r c h
on numerous, partly unknown, male and female factors. If this probability is
zero, a pregnancy will never occur and the couple is truly infertile. However,
true infertility is relatively rare (Greenhall and Vessy, 1990). High fertility,
normal fertility, subfertility and infertility are to be considered as part of a
continuoum, and in many couples there is not one clear-cut cause, but various
more or less obvious reasons why a couple has not (yet) conceived, or no
obvious reason at all (Te Velde e t  a l ., 2000). In that case the subfertility is
called unexplained. Nevertheless, it may be important to understand the
mechanism  also of a relative cause. For example, with regard to the subject of
this thesis: it would be important to find out whether or not LUF could be the
relative explanation of otherwise unexplained infertility or of reproductive
aging. Better understanding of causes and mechanisms is a first condition for
designing appropriate therapeutic approaches.
Second, most couples who come to a doctor with the complaint of infertility,
are either subfertile or even have a normal fertility. Only a small proportion of
them is truly infertile. It is important to be able to distinguish between these
possibilities and  recognize the couples who would benefit from immediate
treatment and those who can better wait some time and try to conceive spon-
taneously (prognostic aim).
Third, if treatment is to be considered, diagnostic tests are important to decide
which modality of treatment is most appropriate for this particular couple
(therapeutic aim).
In this era of scientific progress, it is often assumed that clinical decisions are
firmly based on results of research. The movement of Evidence-Based Medi-
cine (EBM) teaches us, however, that most clinical decisions have no scientifi-
cally proven base. Only with regard to decide whether or not certain modalities
of treatment are useful and effective, considerable progress has been made by
analysing the results of pooled randomized controlled trials (meta-analyses).
Also in reproductive medicine EBM has made some progress, although most
treatments which are applied at present, are not (yet) evidence-based. Be-
cause of the multivariate nature of reproductive medicine, almost no progress
has been made in EBM of diagnostic tests, both with regard to the prognostic
aim and to the therapeutic aim. This statement is sometimes interpreted as if
diagnostic tests in reproductive medicine are more or less worthless.
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In Table 1,  it is attempted to distinguish various levels  of knowledge on
which clinical decisions are based, varying from no knowledge at all to absolute
certainty. We have to conclude, that most of the decisions based on diagnostic
tests in reproductive medicine, have not surpassed the degree of knowledge
present in  level 4. As long as the level of evidence-based medicine has not
been reached, we have to base our clinical decisions on the level of knowledge
present in level 4. The latter two statements also apply for the diagnostic tests
which are studied in this thesis.
Table 1. Levels of knowledge on which clinical decisions are based*
1. No knowledge at all.
2. Speculative knowledge, based on theories and religious notions. Often
authority-based.
3. Biological knowledge, based on laboratory experiments and animal
research.
4. Knowledge based on non-controlled trials, common sense, intuition
and experience. Biological plausibility (level 3) is also integrated in
this level.
5. Evidence-based  knowledge based on the results of randomized
controlled trials.
6. Knowledge which is based on absolute certainty.
* adapted from Te Velde, 1996
With regard to definitions of LUF and other subtle ovulation disorders, we
have to conclude that the confusion is great (Chapter 1). Follicles of normal
pre-ovulatory size that do not rupture after the LH surge, may either continue
to grow (these cycles are called cyst cycles by some authors and LUF cycles
by others), or diminish in size, which cycles are generally called LUF cycles.
Cycles in which follicles do not reach a diameter larger than between 16 and
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17 mm, generally are called poor follicle growth cycles, but asynchronous
cycles by others. In some publications it remains unclear, whether or not such
small follicles ovulated. We propose to reserve the term LUF for those conditions
where, in spite of the fact that the follicle does not rupture, luteinization with
progesterone production occurs and normal cycle regularity is maintained. We
think that in comparison with LUF the clinical relevance of follicles that ovulate
at a too small diameter, is still speculative.
The most important conclusions from the literature with regard to LUF (Chap-
ter 1) are the following.
a . In comparison with subfertile patients LUF is rare in cycles of normal
fertile women (Chapter 1, Tables 5 and 7). The results indicate that
LUF is likely to be a relative cause of subfertility, specially if this is
unexplained (Chapter 1, Table 5).
The recurrence rate is not yet well established (Chapter 1, Table 6),
but it is obvious that LUF cycles can be followed by ovulatory cycles.
b . Whether the presence of LUF is relevant for the prognosis, is com-
pletely unknown.
c. With regard to the therapeutic aim, the results of Table 8 (Chapter 1)
suggest that ovulation induction with gonadotrophins might be ben-
eficial. This suggestion is based on some observational studies (level
4) and needs to be confirmed in RCTs. For the time being, an attempt
to treat LUF with gonadotrophins seems warranted.
The first aim of this thesis was to investigate how frequent disorders of follicle
growth, ovulation and hormonal patterns can be diagnosed in subfertile women
with regular cycles and low serum progesterone levels during the luteal phase
of previous cycles. We performed serial hormonal and ultrasound measure-
ments in a group of 50 women who had relatively low serum progesterone
levels (< 32 nmol/l) in two cycles. According to minimal criteria from the
literature to consider a cycle as normal, 25 cycles showed abnormalities. Four-
teen cycles were classified as LUF cycles. In eight cycles, follicles remained too
small, in 2 cycles no follicle was observed during the LH surge, and in 1 cycle
there was no follicle development. In 16 other cycles progesterone levels
were again relatively low, but because in these cycles normal follicle growth
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and ovulation occurred, it seems not justified to consider such cycles as abnor-
mal. However, it can not be excluded that the ability to conceive during those
cycles is reduced (Hull e t  a l ., 1982). In a sample of 171 women from the total
patient population, almost 9% had two low-progesterone cycles. This would
suggest that in 2-3% of the initial patients a LUF cycle was present. However,
Hamilton e t  a l . (1985) found that half of their LUF patients had progesterone
levels < 32 nmol/l, the other half had levels > 32 nmol/l. If we extrapolate this
figure, this would mean that we missed half of the patients with LUF cycles.
Thus, the real incidence of LUF cycles was estimated at about 5%. We also
concluded that low progesterone levels predict subtle cycle disorders in fol-
lowing cycles. An incidence of about 5% is lower than has been described in
most publications. However, in control groups of normal fertile women, sub-
tle cycle disorders are rarely seen. In our two age-groups of volunteers (22-34
years and 41-46 years, including 61 women in total) who all had succeeded to
become pregnant within one year in the past (Chapter 7), three cycles were
abnormal. None of these cycles were, however, abnormal in the sense of a
LUF cycle. One cycle was too short, the two other cycles showed persisting
follicles, which means that no luteinization occurred. We concluded that LUF
cycles probably occur more often in a subfertile than in a proven fertile popu-
lation. In patient groups, r e c u r r e n c e of subtle cycle disorders, however, with
quite some differences in the incidence, have been found. We could predict
the occurrence of subtle disorders in subsequent cycles. In our opinion this is
an argument in favour of the assumption that subtle cycle disorders recur in at
least a part of the patients.
The second aim of the thesis was to estimate the cost-effectiveness of different
diagnostic procedures to diagnose subtle cycle disorders. The costs were re-
lated to the possible benefits, from literature data. We calculated the costs for
diagnosing such disorders by a maximal diagnostic strategy applying vaginal
ultrasound examinations combined with hormone estimates in all women with
regular cycles; by an ultrasound-only approach in all women; and by a
preselection strategy with progesterone measurements in all women, fol-
lowed by ultrasound and hormone determinations in women who had pro-
gesterone levels < 32 nmol/l in two cycles. If only m e d i c a l costs were consid-
ered, diagnosis of one patient with a subtle cycle disorder using the maximal
strategy required a total medical cost of 9057 european currency units (Euros),
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by ultrasound-only ECU 4520 and by preselection ECU 3036. However, es-
pecially by applying the latter method in a considerable number of cases the
diagnosis may be missed. In several textbooks and articles luteal phase pro-
gesterone measurements in the work-up of subfertile couples are recommended
(Chapter 5), but further diagnostic steps are not mentioned. Based on the
results of our study we conclude that the ultrasound-only approach is the
most cost-effective.
Therapeutic advices include the use of various drugs for ovulation induction
treatment. Results of these treatments, reported in the literature, are promising
(Chapter 1, Table 8).
We conclude that it may be useful to search for subtle ovulation disorders in
the work-up of regularly cycling subfertile women. Research on providing
knowledge on level 5 (Table 1) with regard to the prognostic aim, would
require to investigate many women with LUF cycles and compare them to
women with ovulatory cycles, but otherwise the same characteristics, and
follow them for several cycles in order to be able to conclude whether the
presence of LUF is a poor prognostic sign. With regard to the therapeutic aim,
a large group in which LUF was found, should be treated and (randomly)
compared with women with LUF without treatment. It probably is difficult to
motivate a sufficient number of patients to participate in such demanding,
multicentered, studies. In this era of in vitro fertilization (IVF), patients can be
offered a treatment that could be expected to bypass several cycle anomalies,
but to the best of our knowledge this has not been investigated. IVF treat-
ments are emotionally and financially demanding and have several risks, in-
cluding multiple pregnancies, the ovarian hyperstimulation syndrome, bleed-
ing and infection.
The third aim of the thesis was to investigate whether ovulation disorders or
abnormal hormonal patterns occur frequently in women with oligo- or amen-
orrhoea who receive a symptomatic treatment (ovulation induction) with the
estrogen receptor blocking agent clomiphene citrate (CC). We compared the
first treatment cycles of 24 patients with cycles of 27 age-matched control
women who had proven their natural fertility in the past. In 11 CC-stimulated
cycles no follicle development whatsoever occurred. One cycle showed the
features of a LUF cycle and the remaining 12 cycles were ovulatory. We con-
cluded that an increased rate of subtle cycle disorders is not an explanation for
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a discrepancy between assumed ovulation rate and pregnancy rate with CC. A
further observation in this study was that in 4 of 10 hormonally evaluable
patients a temporary decline of estradiol levels was present between cycle
days 7 and 11, compared to 1 woman in the control group. It appeared that in
those cycles the estradiol levels reached higher values on cycle day 7 or 8 than
in cycles not showing an estradiol-decline. Higher estradiol levels appeared to
be positively related to age, and we hypothesized that follicles of the older
women show a diminished production of inhibin in response to ovarian stimu-
lation. As a consequence the negative feedback towards the central system is
subnormal in the older patients, resulting in higher follicle-stimulating hor-
mone (FSH) levels (Hughes e t  a l ., 1990). It is unknown, whether cycles show-
ing high and temporally declining estradiol levels are less fertile. To investi-
gate this, many cycles should be analyzed. If such cycles would appear to be
less fertile, another therapy could be chosen, thus saving the patients time
and efforts. A matter of interest is, whether such patterns of estradiol can be
used as a diagnostic test for ovarian aging. At present a clomiphene challenge
test is in use, in which, after administering 100 mg of clomiphene citrate daily
during cycle day 5-9, an FSH level on cycle day 10 that exceeds a certain
threshold is used as an index of ovarian competence. The value of this test,
however, has been challenged (Bancsi e t  a l ., 2001). Possibly, adding the
estradiol-response on cycle day 7 or 8 may improve the predictive value of
this test. Licciardi e t  a l . (1995) found that relatively high estradiol levels on
cycle day 3 predicted low oocyte yields and low pregnancy rates after IVF in
the same cycles. Evers e t  a l . (1998) showed that  normal early follicular FSH
levels, in combination with high estradiol levels, in a preceding cycle, pre-
dicted a poor response to stimulation for IVF. In an alternative CC-challenge
test, as proposed above, it may be advantageous to combine the estradiol
levels on cycle day 3 (before CC) and cycle day 7-8.
The fourth aim of the thesis was to obtain reference values for cycle normality
from a group of relatively young fertile women (22-34 years) with regular
menstrual cycles, and to evaluate whether follicle growth, ovulation, endome-
trial development and hormonal patterns in older women (41-46 years) differ
from the reference group, and, if present, whether such differences may ex-
plain, or contribute to, the age-related loss of fertility. The women in both
groups had became pregnant within a year in the past. The older group in-
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cluded women with an age-range in which fertility can be expected to be
greatly impaired. The younger women were in an age-range in which fertility
is optimal or only slightly diminished. The size and growth of follicles were
followed by vaginal ultrasound, and levels of several hormones were meas-
ured during the cycle. It appeared that clearly abnormal cycles were rare: in
the older group 2, compared to 1 in the younger women. This means that
cycle disorders such as a LUF and other subtle cycle disorders do not explain
the age-related decline of fertility. Some differences were found between the
age groups. The total cycle length was shorter in the older women, which was
caused by a shorter follicular phase. Until now, such a shorter follicular phase
is thought to result from a faster growth of follicles, starting in the early follicular
phase (accelerated follicle development). Our results indicate, however, that
there is no difference in the time-span in which follicles are recruited and
stimulated to further growth, the dominant follicle is selected, and ovulation
takes place. The difference between older and younger women is a sh i f t  in
t i m e of 2-3 days of follicle development and estradiol increase which already
starts during the late luteal phase of the preceding cycle. Our results clearly
demonstrate that there is an advanced follicle development instead of an
accelerated one. The earlier rise of FSH levels in the older group, starting
already during the luteal phase of the preceding cycle, could well be the
trigger for earlier follicle growth and further development. We hypothesize
that the earlier rise of FSH is caused by a diminished production of inhibin A
by the corpus luteum of the older women (Danforth e t  a l ., 1998, Santoro e t  a l .,
1999). Inhibin is known to lower selectively the pituitary FSH production, by
a negative feedback mechanism. Estradiol and progesterone both have a nega-
tive feedback on FSH (and LH), but estradiol and progesterone levels did not
differ during the luteal phase between both groups. The fall of progesterone,
at the end of the life-span of the corpus luteum, is responsible for the onset of
the menstrual period (Le Nestour e t  a l ., 1993). Therefore, the earlier rise of
FSH can advance follicle development without advancing menstruation. An-
other difference between the age groups was a decreasing growth rate of the
dominant follicle during the 3 days preceding ovulation in the older women,
resulting in a smaller diameter before ovulation. Estradiol levels and endome-
trial thickness did not differ in this stage of the cycle. It is generally believed
that the decline of fertility with age results from a decline in oocyte quality, by
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an increasing incidence of chromosomal aberrations. However, less favour-
able conditions during follicle development may contribute to this. The earlier
start, during the preceding luteal phase, may occur during a suboptimal hor-
monal environment. The smaller follicle diameter before ovulation may be a
reflection of such a less favourable start. Other reasons why follicle quality
(and consequently oocyte quality) may be diminished is the lower number of
recruitable follicles (due to a diminished resting follicle pool) during the FSH-
window which may lead to an exposure to FSH of these follicles that lasts too
short for optimal further development (Warburton, 1989). In addition, selec-
tion of a dominant follicle from a smaller cohort may, just by chance, results in
a follicle of less quality. It is tempting to speculate that the advanced follicle
development in older women can be manipulated. It has been shown  by Le
Nestour e t  a l . (1993) that the early follicular FSH rise can be postponed by the
administration of physiological amounts of estrogens. Advantages of such a
procedure could be a better timing of the postcoital test (De Ziegler e t  a l .,
1999) or better timing of intra-uterine insemination (De Ziegler e t  a l ., 1998;
1999). Another suggestion is that at the start of a hyperstimulated cycle for IVF
endogenous and exogenous FSH could be better synchronized (De Ziegler e t
a l ., 1998). It might also be possible to postpone the earlier FSH rise in older
women from the late luteal phase of the preceding cycle towards the early
follicular phase, the normal situation in younger women. Whether follicle
growth and hormonal events would resemble more those of younger women,
and whether this results in a more fertile cycle, could be the subject of further
research.
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Hoofdstuk 9
Algemene discussie, samenvatting, en aanwijzingen voor toekomstig
onderzoek
In dit proefschrift worden enkele diagnostische tests ter discussie gesteld, die
worden uitgevoerd bij subfertiele vrouwen met ogenschijnlijk normale en
regelmatige cycli, en bij normale maar oudere vrouwen die nog een regelmatig
menstruatiepatroon hebben. De diagnostische tests betreffen echoscopische
metingen en hormonale patronen die de aan- of afwezigheid van een normale
ontwikkeling van follikels, ovulatie, en functie van het corpus luteum aangeven,
bij vrouwen met een normaal en regelmatig patroon van hun cyclus.
Anovulatoire stoornissen die gepaard gaan met oligo- en amenorroe, zijn
bekende oorzaken van een verminderde vruchtbaarheid van vrouwen, die
met goed resultaat kunnen worden behandeld (Hull e t  a l ., 1985). Er is veel
minder bekend over subtiele stoornissen van de follikelgroei, en over hormonale
ontregeling bij vrouwen die regelmatige menstruele cycli hebben. Bovendien
is er weinig bekend over  vrouwen die ouder zijn dan 40 jaar en nog regelmatig
menstrueren, terwijl wij weten dat hun vruchtbaarheid sterk is afgenomen.
Een  r ege lma t i g e  c y c l u s  be t eken t  d a t  d e  i ngew ikke lde  ho rmona l e
terugkoppelingsmechanismen, die beheerst worden door de groei van follikels
en de ontwikkeling van een corpus luteum, intact zijn, en dat verwacht kan
worden dat de kwaliteit van zon follikel normaal is.
De algemene doelstelling van dit proefschrift was deze tegenstelling te belichten:
is het werkelijk waar dat vrouwen met een regelmatige cyclus subtiele
verstoringen van hun cyclus kunnen hebben? Hoe vaak komen deze voor en
hoe kunnen wij de diagnose stellen? Kunnen zij beschouwd worden als een
verklaring voor de afgenomen vruchtbaarheid, of de onvruchtbaarheid, en
hoe kunnen we deze kennis gebruiken voor het beleid bij verminderd
vruchtbare patiºnten?
Er zijn verscheidene redenen waarom diagnostische tests worden uitgevoerd
in de geneeskunde, waaronder de voortplantingsgeneeskunde
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(Te Velde e t  a l ., 1995).
In de eerste plaats kan een diagnose belangrijk zijn om de oorzaak en het
mechanisme van de ziekte te begrijpen, in overeenstemming met het klassieke
medisch-wetenschappelijke uitgangspunt: alleen als we weten waardoor een
pat iºnt  z iek is ,  kunnen we een goede behandel ing bedenken.  In de
voortplantingsgeneeskunde is het echter moeilijker dit principe toe te passen,
omdat vruchtbaarheid en onvruchtbaarheid geen alles of niets verschijnselen
zijn zoals gezondheid en ziekte. Of een vrouw al of niet zwanger zal worden
binnen een zeker  t i jds interval ,  wordt  bepaald door de maandel i jkse
zwangerschapskans, die afhankelijk is van talrijke, gedeeltelijk onbekende,
mannelijke en vrouwelijke factoren. Als deze kans nul is, zal een zwangerschap
nooit optreden, en in dat geval is het paar werkelijk onvruchtbaar. Echter,
echte onvruchtbaarheid is relatief zeldzaam (Greenhall and Vessy, 1990). Hoge
vruchtbaarheid, normale vruchtbaarheid, verminderde vruchtbaarheid en
onvruchtbaarheid kunnen worden beschouwd als onderdelen van een glijdende
schaal, en bij veel paren is er niet ØØn duidelijke oorzaak, maar zijn er
verschillende, meer of minder duidelijke oorzaken waardoor een paar (nog)
geen zwangerschap heeft bereikt, of is er in het geheel geen duidelijke oorzaak
(Te Velde e t  a l .,  2000). In dat geval wordt de vruchtbaarheidsstoornis
onverklaard genoemd. Niettemin kan het belangrijk zijn om ook het
werkingsmechanisme van een relatieve oorzaak te begrijpen. Bijvoorbeeld,
met betrekking tot dit proefschrift: het zou van belang zijn te ontdekken of (of
luteinized unruptured follicle (LUF) cycli al of niet de relatieve verklaring
kunnen zijn van een overigens onverklaarde vruchtbaarheidsstoornis, of van
de leeftijdsafhankelijke afname van de vruchtbaarheid. Een beter begrip van
de oorzaken en de mechanismen is een eerste voorwaarde voor het ontwerpen
van een doeltreffende behandeling.
In de tweede plaats zijn de meeste paren die naar een arts gaan met als klacht
dat er nog geen zwangerschap is ontstaan, óf slechts verminderd vruchtbaar,
óf zelfs normaal vruchtbaar. Slechts een klein deel van hen is werkelijk
onvruchtbaar. Het is belangrijk, onderscheid te kunnen maken tussen deze
mogelijkheden, en de paren te herkennen die zouden profiteren van een
onmiddellijke behandeling, evenals de paren die beter enige tijd kunnen
wachten om te proberen spontaan een zwangerschap tot stand te brengen
(prognostische doelstelling).
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In de derde plaats zijn, als een behandeling wordt overwogen, diagnostische
tests belangrijk om te beslissen welke behandelwijze het meest bij dit
afzonderlijke patiºntenpaar past (therapeutische doelstelling).
In dit tijdperk van wetenschappelijke vooruitgang wordt vaak aangenomen
dat kl inische besl iss ingen stevig zi jn gebaseerd op de resultaten van
wetenschappelijk onderzoek. De movement of Evidence-Based Medicine (EBM,
dit is een proces van systematisch opzoeken, beoordelen en samenvatten van
bij voorkeur gerandomiseerde studies) leert ons echter dat de meeste klinische
beslissingen geen wetenschappelijk bewezen basis hebben. Uitsluitend om te
kunnen uitmaken of bepaalde behandelmethoden nuttig en effectief zijn, is er
aanzienlijke vooruitgang geboekt door het analyseren van de resultaten van
gepoo lde  gecont ro l ee rde  onderzoeken  (meta -ana l y se s ) .  Ook  in  de
voortplantingsgeneeskunde heeft EBM enige vooruitgang geboekt, hoewel de
meeste vormen van behandeling die worden toegepast, (nog) niet evidence-
based zijn. Doordat in de voortplantingsgeneeskunde vele factoren een bijdrage
leveren, is er bijna geen vooruitgang geboekt in de EBM van diagnostische
tests, zowel wat betreft de prognostische als de therapeutische doelstelling.
Deze vaststelling wordt soms uitgelegd alsof diagnostische tests in de
voortplantingsgeneeskunde in meerdere of mindere mate zonder waarde zijn.
In Tabel 1 wordt getracht verschillende niveaus van kennis te onderscheiden
waarop klinische beslissingen zijn gebaseerd, variºrend van totaal geen kennis
t o t  a b s o l u t e  z e k e r h e i d .  W e  m o e t e n  c o n c l u d e r e n  d a t  i n  d e
voortplantingsgeneeskunde de meeste beslissingen die gebaseerd zijn op
diagnostische tests, niet uitkomen boven het kennisniveau dat overeenkomt
met niveau 4. Zolang het niveau van de evidence-based medicine niet is bereikt,
moeten we onze klinische beslissingen baseren op de kennis van niveau 4. De
laatste twee opmerkingen zijn ook van toepassing op de diagnostische tests
die in dit proefschrift het onderwerp van studie zijn.
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Tabel 1. Niveaus van kennis waarop het klinische handelen is gebaseerd*
1. Geen enkele kennis.
2. Speculatieve kennis gebaseerd op theoretische en religieuze
overwegingen. Dikwijls gebaseerd op autoriteit.
3. Biologische kennis op grond van laboratoriumbevindingen of
dierexperimenten.
4. Kennis gebaseerd op niet-gecontroleerde studies, gezond verstand,
intuïtie en ervaring. Biologische plausibiliteit (niveau 3) behoort
ooktot dit niveau.
5. Ev idence -based  :  kenn i s  op  bas i s  van  de  r e su l t a t en  van
gerandomiseerd gecontroleerd klinisch onderzoek.
6. Kennis gebaseerd op absolute zekerheid.
* naar Te Velde, 1996
Wat betreft de definitie van LUF en andere subtiele ovulatiestoornissen, moeten
we vaststellen dat de verwarring groot is (Hoofdstuk 1). Follikels met normale
pre-ovulatoire afmetingen die niet springen na de LH piek, kunnen óf
doorgroeien (deze cycli worden door sommige auteurs cyste-cycli genoemd,
en LUF cycli door andere), óf kleiner worden, welke cycli in het algemeen
LUF cycli worden genoemd. Cycli waarin de follikels niet een doorsnede
bereiken die groter is dan tussen 16 en 17 mm, worden in het algemeen cycli
met slecht groeiende follikels genoemd, maar door anderen asynchrone cycli.
In sommige publikaties blijft het onduidelijk of zulke kleine follikels al of niet
ovuleerden. Wij stellen voor de term LUF te reserveren voor die omstandigheden
waarin, ondanks het feit dat de follikel niet springt, luteïnisering gepaard
gaande met  de  product ie  van progesteron optreedt ,  en de  normale
regelmatigheid van de cyclus blijft bestaan. Wij denken, dat in vergelijking met
LUF het klinische belang van follikels die ovuleren bij een te kleine diameter,
nog geheel speculatief is.
156
Hoofdstuk 9
De belangrijkste conclusies uit de literatuur met betrekking tot LUF (Hoofdstuk
1) zijn de volgende:
a . In vergelijking tot subfertiele patiºnten is LUF zeldzaam in cycli van
normaal vruchtbare vrouwen (Hoofdsuk 1, Tabel 5 en 7). De resultaten
maken waarschijnlijk dat LUF een relatieve oorzaak is van verminderde
vruchtbaarheid, in het bijzonder als deze onverklaard is (Hoofdstuk 1,
Tabel 5).
De mate van herhaling is nog niet goed vastgesteld (Hoofdstuk 1, Tabel
6), maar het is duidelijk dat LUF cycli kunnen worden gevolgd door
ovulatoire cycli.
b . Of de aanwezigheid van LUF cycli van belang is voor de prognose, is
geheel onbekend.
c. Met betrekking tot de therapeutische doelstelling, suggereren de resultaten
in Tabel 8 (Hoofdstuk 1) dat ovulatie-inductie met gonadotrofinen van
voordeel zou kunnen zijn. Dit is gebaseerd op enkele waarnemings-
onderzoeken (kennisniveau 4), maar dit moet nog worden bevestigd
met gerandomiseerd onderzoek, in vergelijking met een controlegroep.
Vooralsnog lijkt een poging om LUF met gonadotrofinen te behandelen
gerechtvaardigd.
De eerste doelstelling van dit proefschrift was te onderzoeken hoe frequent
stoornissen in de follikelgroei, de ovulatie en de hormonale patronen kunnen
worden vastgesteld bij subfertiele vrouwen met een regelmatige cyclus en
lage progesteronwaarden in het bloedserum tijdens de luteale fase van
voorafgaande cycl i .  Wij deden opeenvolgende hormoonbepalingen en
echoscopische metingen bij een groep van 50 vrouwen die relatief lage serum-
progesteronwaarden (< 32 nmol/l) hadden in 2 cycli. Volgens minimale criteria
vanuit de literatuur, om een cyclus als normaal te mogen beschouwen, toonden
25 cycli afwijkingen. Veertien cycli werden geklassificeerd als LUF cycli. In 8
cycli bleven de follikels te klein, in 2 cycli werd geen follikel waargenomen
tijdens de LH piek, en in 1 cyclus was er geen ontwikkeling van een follikel. In
16 andere cycli waren de progesteronwaarden opnieuw relatief laag, maar
aangezien in deze cycli een normale follikelgroei en ovulatie optraden, lijkt
het niet gerechtvaardigd deze cycli als abnormaal te beschouwen. Het kan
echter niet worden uitgesloten dat de mogelijkheid om in deze cycli zwanger
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te worden, is verminderd (Hull e t  a l ., 1982). In een steekproef van 171 vrouwen
uit de totale patiºntenpopulatie had bijna 9% van hen 2 cycli met lage
progesteronwaarden. Dit zou kunnen betekenen dat bi j  2-3% van de
oorspronkelijke patiºnten een LUF cyclus aanwezig was. Echter, Hamilton e t
a l . (1985) vonden dat de helft van hun LUF patiºnten progesteronwaarden <
32 nmol/l hadden, de andere helft > 32 nmol/l. Als we dit getal extrapoleren,
zou dat betekenen dat wij de helft van de patiºnten met LUF cycli zouden
hebben gemist. Daarom werd de werkelijke incidentie van LUF cycli geschat
op ongeveer 5%. Wij concludeerden ook, dat lage progesteronwaarden een
voorspellende waarde hebben voor het optreden van subtiele stoornissen in
een volgende cyclus.
Een incidentie van ongeveer 5% is lager dan in de meeste publicaties is
beschreven. Echter, bij controlegroepen van normaal vruchtbare vrouwen
worden subtiele cyclusstoornissen zelden gezien. In onze twee leeftijdsgroepen
van vrijwilligsters (22-34 jaar en 41-46 jaar, totaal 61 vrouwen), die er allen in
het verleden in waren geslaagd binnen een jaar zwanger te worden (Hoofdstuk
7), waren 3 cycli afwijkend. Geen van deze cycli was echter afwijkend in de
zin van een LUF cyclus. EØn cyclus was te kort, de 2 andere cycli toonden een
persisterende follikel, hetgeen betekent dat er geen luteïnisatie optrad. Wij
concludeerden dat LUF cycli waarschijnlijk vaker voorkomen in een verminderd
vruchtbare dan in een bewezen vruchtbare populatie. In patiºntengroepen is
h e r h a l i n g, echter met een nogal verschillende incidentie, gevonden. Wij bleken
het optreden van subtiele afwijkingen in een volgende cyclus te kunnen
voorspellen. Naar onze mening is dit een argument voor de veronderstelling
dat subtiele cyclusstoornissen zich herhalen bij ten minste een deel van de
patiºnten.
De tweede doelstelling van het proefschrift was het bepalen van de kosten-
effect iv i te i t  van verschi l lende diagnost ische procedures om subt ie le
cyclusstoornissen vast te stellen. De kosten werden gerelateerd aan de mogelijke
voordelen voor de patiºnten, op basis van literatuurgegevens. Wij berekenden
de kosten voor het stellen van de diagnose met een maximaal diagnostische
strategie waarbij vaginaal echoscopisch onderzoek werd gebruikt, in combinatie
met hormoonbepalingen bij alle vrouwen met een regelmatige cyclus; een
uitsluitend echoscopie strategie bij alle vrouwen; en een voorselectie strategie
met progesteronbepalingen bij alle vrouwen, gevolgd door echoscopie en
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hormoonbepalingen bij vrouwen die in 2 cycli uitsluitend progesteronwaarden
< 32 nmol/l hadden. Indien alleen m e d i s c h e kosten werden beschouwd, vereiste
de diagnose van een subtiele cyclusstoornis per patºnte met behulp van de
maximale strategie een bedrag van 9.057 euro aan totale medische kosten, de
uitsluitend echo strategie 4.520 euro, en de voorselectie strategie 3.036 euro.
Bij het toepassen van de laatstgenoemde methode kan echter in een aanzienlijk
aantal gevallen de diagnose worden gemist. In verscheidene leerboeken en
artikelen worden progesteronbepalingen bij de diagnostiek van subfertiele
paren aanbevolen (Hoofdstuk 5), maar verdere diagnostische stappen worden
hierbij niet genoemd. Op basis van de resultaten van ons onderzoek concluderen
wij dat de uitsluitend echoscopie aanpak de meest kosten-effectieve is.
Behandeladviezen betreffen de toepassing van diverse medicamenten voor
ovulatie-inductie behandeling. De resultaten hiervan, zoals die zijn gepubliceerd,
zijn veelbelovend (Hoofdstuk 1, Tabel 8).
Wij trokken de conclusie, dat het nuttig kan zijn bij de diagnostiek van subfertiele
vrouwen met een regelmatige cyclus subtiele ovulatiestoornissen op te sporen.
Research met het doel kennis te vergaren op niveau 5 (Tabel 1) om te
beantwoorden aan de prognostische doelstelling, zou vereisen dat veel vrouwen
met LUF onderzocht moeten worden, en worden vergeleken met vrouwen die
een ovulatoire cyclus, maar overigens dezelfde kenmerken hebben. Zij zouden
gedurende meerdere cycli vervolgd moeten worden om te kunnen concluderen
of de aanwezigheid van LUF cycli een prognostisch ongunstig teken is. Om
aan de therapeutische doelstelling te kunnen beantwoorden, zou een grote
groep vrouwen bij wie LUF cycli werden gevonden, at random moeten worden
verdeeld in een groep die wel, en een groep die niet wordt behandeld. Het is
waarschijnlijk moeilijk een voldoende groot aantal vrouwen te motiveren om
aan zodanig  veeleisende multicenter onderzoeken deel te nemen. In dit tijdperk
van in vitro fertilisatie (IVF) kan de patiºnten een behandeling worden geboden,
waarvan te verwachten valt dat deze verscheidene cyclusanomalieºn kan
omzeilen, maar voor zover ons bekend, is dit nooit onderzocht. IVF
behandelingen zijn in emotioneel en financieel opzicht belastend en brengen
diverse risicos met zich mee, zoals meerlingzwangerschappen, het ovarieel
hyperstimulatiesyndroom, bloeding en infectie.
De derde  doe l s te l l ing  van  het  proefschr i f t  was  te  onderzoeken of
ovulatiestoornissen of afwijkende hormonale patronen frequent voorkomen
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bij vrouwen met oligo- of amenorroe, die hiervoor een symptomatische
behandeling ontvangen (ovulatie-inductie) met de oestrogeen receptor
blokkerende stof clomifeen citraat (CC). Wij vergeleken de eerste behandelcyclus
van 24 patiºnten met cycli van 27 controlevrouwen van dezelfde leeftijdsgroep,
die hun natuurlijke vruchtbaarheid eerder hadden bewezen. In 11 cycli die
met CC werden gestimuleerd, trad in het geheel geen ontwikkeling van een
follikel op. EØn cyclus toonde de kenmerken van een LUF cyclus, en de overige
12 cycli waren ovulatoir. Wij concludeerden hieruit, dat een toegenomen mate
van voorkomen van subtiele cyclusstoornissen geen verklaring vormt voor
een d iscrepant ie  tussen het  de  percentages  ovula t ies  per  cyc lus  en
zwangerschappen per cyclus. Een verdere waarneming in deze studie was dat
bij 4 van 10, wat hormoonbepalingen betreft goed te evalueren patiºnten, een
tijdelijke daling de oestrogeenconcentraties aanwezig was tussen cyclusdag 7
en 11, in vergelijking tot 1 vrouw in de controlegroep. Het bleek dat in deze
cycli de bloedspiegels van oestradiol hogere waarden bereikten op cyclusdag
7 of 8 dan in cycli die geen oestradioldaling vertoonden. Verder bleek dat
hogere oestradiolwaarden positief correleerden met de leeftijd. Wij stelden de
hypothese op, dat follikels van oudere vrouwen een verminderde productie
van inhibine tonen in respons op stimulatie van de ovaria. Als gevolg hiervan,
is de negatieve terugkoppeling naar het centrale systeem bij de oudere patiºnten
subnormaal, hetgeen leidt tot hogere spiegels van het follikel stimulerend
hormoon (FSH) (Hughes e t  a l ., 1990). Het is onbekend of in cycli waarin
hoge, en tijdelijk dalende, oestradiolspiegels voorkomen, de vruchtbaarheid
lager is. Om dit te onderzoeken zouden vele cycli nodig zijn. Als in zulke cycli
de vruchtbaarheid verminderd zou blijken te zijn, zou voor een andere
behandeling kunnen worden gekozen, hetgeen de patiºnte tijd en inspanning
zou besparen. Van belang is, of  het verloop van de oestradiolspiegels zou
kunnen worden gebruikt als diagnostische test op ovariºle veroudering.
Tegenwoordig wordt een clomifeenbelastingstest gebruikt, waarbij, na toedienen
van 100 mg clomifeen citraat per dag gedurende cyclusdag 5-9 een FSH
bloedspiegel op cyclusdag 10 die een bepaalde grenswaarde overschrijdt, wordt
gebruikt als een kenmerk voor de kwaliteit van de functie van het ovarium.
De waarde van deze test is echter omstreden (Bancsi e t  a l ., 2001). Mogelijk
kan het toevoegen van de oestradiolrespons op cyclusdag 7 of 8 de
voorspellende waarde van deze test verhogen. Licciardi e t  a l . (1995)
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vonden dat relatief hoge oestradiolwaarden op cyclusdag 3 binnen dezelfde
cyclus een lage eicelopbrengst en lage zwangerschapscijfers na een IVF
behandeling konden voorspellen. Evers e t  a l . (1998) toonden aan dat normale
vroeg-folliculaire FSH spiegels in combinatie met hoge oestrogeenspiegels, in
een voorafgaande cyclus, een lage respons op stimulatie voor IVF voorspelden.
In een alternatieve clomifeenbelastingstest zoals hierboven voorgesteld, zou
het van voordeel  kunnen zi jn ,  de oestradiolwaarden op cyclusdag 3
(voorafgaand aan clomifeen citraat) te combineren met die op cyclusdag 7-8.
De v ierde  doe ls te l l ing  van het  proefschr i f t  was  het  verkr i jgen van
referentiewaarden voor het al of niet normaal zijn van een cyclus, vanuit een
groep relatief jonge vruchtbare vrouwen (22-34 jaar oud) met een regelmatige
m e n s t r u e l e  c y c l u s ,  e n  n a  t e  g a a n  o f  d e  f o l l i k e l g r o e i ,  o v u l a t i e ,
endometriumontwikkeling en hormonale patronen van oudere vrouwen (41-
46 jaar oud) verschillen van de referentiegroep, en als dat zo blijkt te zijn, of
zulke verschillen de leeftijdsafhankelijke daling van de vruchtbaarheid kunnen
verklaren, of eraan kunnen bijdragen. De vrouwen van beide groepen waren
in het verleden binnen een jaar zwanger geworden. De oudere groep bestond
uit  vrouwen in een leeft i jd  waarop kan worden aangenomen dat  de
vruchtbaarheid in sterke mate is afgenomen. De jongere vrouwen waren op
een leeftijd waarbij de vruchtbaarheid nog optimaal is, of slechts licht
verminderd. De afmetingen en de groei van de follikels werden in het verloop
van de cyclus gevolgd met transvaginaal echoscopisch onderzoek, en de
bloedspiegels van verscheidene hormonen werden gemeten. Het bleek, dat
duidelijk abnormale cycli weinig voorkwamen: in de oudere groep 2, vergeleken
met 1 bij de jongere vrouwen. Dit betekent dat cyclusstoornissen zoals LUF en
andere subtiele cyclusstoornissen niet de verklar ing vormen voor de
leeftijdsafhankelijke afname van de vruchtbaarheid. Er werden enkele verschillen
gevonden tussen de leeftijdsgroepen. De totale lengte van de cyclus was kleiner
bij de oudere vrouwen, hetgeen werd veroorzaakt door een kortere folliculaire
fase. Tot nu toe werd gedacht dat zon kortere folliculaire fase het gevolg is
van een snellere groei van de follikels, die start in de vroege folliculaire fase
(versnelde follikelontwikkeling). Onze resultaten geven echter aan, dat er
geen verschil is in het tijdsverloop waarin de follikels worden gerekruteerd en
gestimuleerd tot verdere groei, de dominante follikel wordt geselecteerd, en
de ovulatie plaatsvindt. Het verschil tussen oudere en jongere vrouwen is een
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v e r s c hu i v i n g  i n  d e  t i j d  van twee tot drie dagen in de ontwikkeling van de
follikels en de oestradiol stijging, die al begint tijdens de laat-luteale fase van
de voorafgaande cyclus. Onze resultaten tonen duidelijk aan dat er een
vervroegde follikelontwikkeling in plaats van een versnelde ontwikkeling
is. De eerder optredende stijging van de FSH spiegels in de oudere groep, die
al start tijdens de luteale fase van de voorafgaande cyclus zou heel goed de
trigger voor een eerder startende groei en verdere ontwikkeling van de
follikelgroei kunnen zijn. Onze hypothese hiervoor is dat de eerdere stijging
van het FSH wordt veroorzaakt door een verminderde productie van inhibine
A door het corpus luteum van de oudere vrouwen (Danforth e t  a l ., 1998,
Santoro e t  a l ., 1999). Het is bekend dat inhibine selectief de productie van het
FSH door  de  hypofyse  kan ver lagen door  midde l  van een negat ie f
terugkoppelingsmechanisme. Oestradiol en progesteron hebben beide een
negatieve terugkoppeling op het FSH (en LH), maar de oestradiol en
progesteronspiegels verschilden niet tussen beide groepen tijdens de luteale
fase. De sterke daling van het progesteron aan het eind van de levensduur van
het corpus luteum, is verantwoordelijk voor het begin van de menstruatie (Le
Nestour e t  a l ., 1993). Daardoor kan de eerdere stijging van het FSH de
ontwikkeling van de follikel vervroegen zonder dat de menstruatie vervroegd
optreed. Een ander verschil tussen de leeftijdsgroepen was een afnemende
groeisnelheid van de dominante fol l ikel gedurende de drie dagen die
voorafgingen aan de ovulatie bij de oudere vrouwen, hetgeen resulteerde in
een kleinere doorsnede voor de ovulatie. De oestradiolspiegels en de dikte
van het endometrium verschilden niet in dit stadium van de cyclus. Het wordt
algemeen aangenomen dat de afname van de vruchtbaarheid met de leeftijd
het gevolg is van een afname van de eicelkwaliteit, door een toeneming van
het optreden van chromosomale afwijkingen. Echter, minder gunstige
omstandigheden tijdens de ontwikkeling van de follikel zouden hiertoe kunnen
bijdragen. De vroegere start, tijdens de voorafgaande luteale fase, zou kunnen
plaatsvinden onder suboptimale hormonale omstandigheden. De kleinere
doorsnede van de follikel voorafgaand aan de ovulatie zou een weerspiegeling
kunnen zijn van zon minder gunstige start. Andere oorzaken waardoor de
follikelkwaliteit verminderd zou kunnen zijn is het kleinere aantal rekruteerbare
follikels (als gevolg van een afgenomen voorraad rustende follikels) tijdens
het FSH-venster, wat zou kunnen leiden tot een blootstelling van deze follikels
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aan FSH die te kort van duur is voor een optimale verdere ontwikkeling
(Warburton, 1989). Bovendien kan selectie van een dominante follikel uit een
kleiner cohort, uitsluitend door toeval, resulteren in de groei van een minder
goede follikel. Het is verleidelijk om te veronderstellen dat de vervroegde
follikelontwikkeling bij oudere vrouwen kan worden gemanipuleerd. Le Nestour
e t  a l . (1993)  toonde aan dat de vroeg-folliculaire FSH stijging kan worden
uitgesteld door het toedienen van fysiologische hoeveelheden oestrogenen.
De voordelen van zon procedure zouden kunnen zijn: een verbeterde timing
van de postcoïtum test (De Ziegler e t  a l ., 1999) of een verbeterde timing van
intra-uteriene inseminaties (De Ziegler e t  a l ., 1998; 1999) Nog een suggestie is
dat bij het begin van een hyperstimulatiecyclus voor IVF het endogene en
exogene FSH beter zouden kunnen worden gesynchroniseerd (De Ziegler e t
a l ., 1998). Het zou ook mogelijk kunnen zijn de vervroegde FSH stijging bij
oudere vrouwen vanuit de laat-luteale fase van de voorafgaande cyclus naar
voren te schuiven in de vroeg-folliculaire fase, de normale situatie bij jongere
vrouwen. Of de follikelgroei en de hormonale processen dan meer op die van
jongere vrouwen zouden lijken, en of dit tot een meer vruchtbare cyclus leidt,
zou het onderwerp van verder onderzoek kunnen zijn.
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DANKWOORD
Heel veel mensen hebben zich voorafgaand aan het verschijnen van dit
proefschrift voor mij ingespannen. Ik weet zeker dat een aantal van hen mij
nu niet te binnen schiet. Deze mensen wil ik in de eerste plaats bedanken.
Mijn ouders. Lieve pa en ma. Ik heb veel redenen tot dank, maar vooral dank
ik jullie voor het onvoorwaardelijke vertrouwen dat jullie in mij stelden,
waardoor ik in vrijheid mijn weg heb kunnen bepalen. Pa had zich erg op het
verschijnen van dit proefschrift verheugd, maar hij kon het helaas niet meer
meemaken.
Prof. dr. E.R. te Velde, beste Egbert, hoofd van de afdeling FENDO en promo-
tor. Ik dank je vooral voor je vertrouwen dat het met mijn proefschrift wel een
keer goed zou komen. Ik bewonder je om je geduld en vasthoudendheid.
Ook om je vermogen altijd weer een stap verder te denken.
Dr. F.J.M. Broekmans, beste Frank. Als co-promotor heb je een stimulerende
rol vervuld. Je gevoel voor kwaliteit uitte zich onder andere bij onze
gezamenlijke worsteling met de grafieken. Je bent de kamergenoot en collega
die ieder zich zou wensen. Geweldig dat je ook mijn paranimf wilde zijn.
Dr. H.P.F. Koppeschaar, beste Hans. Vele donderdagavonden hebben wij samen
gewerkt in jouw gastvrije huis, aan het bewerken van de patiºntengegevens.
Ik heb grote waardering voor je aandacht voor de ruwe data, die je nooit uit
het oog verloor. Ik hoop  nog lange tijd op deze manier met je samen te
werken. Dat jouw lieve vrouw Jeanne er niet meer bij kan zijn, vervult mij met
een groot verdriet. Ik ben blij met jou als co-promotor.
Prof. dr. D.D.M. Braat, beste Didi. Ik heb de beste herinneringen aan de
samenwerking met jou aan de VU. Niemand kan zo snel een patiºnt van de
verloskamer naar de OK krijgen als jij. Wij hebben heel wat sectios samen
gedaan. Ik was erg getroffen door jouw enthousiaste reactie toen ik je vroeg
mijn paranimf te zijn.
Prof. dr. M.A. Blankenstein, beste Rien. Jij, en ook je medewerkers op het
Endocrinologie-laboratorium stonden altijd klaar met adviezen, het doen van
extra lab-bepalingen en zelfs het malen van bijnierweefsel. Je snelheid bij het
geven van advies verbaasde me meermalen. Dank voor de geweldige
samenwerking. Het ga je goed aan de VU in Amsterdam. Ik ben blij dat je in
de promotiecommissie wilde plaatsnemen.
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Prof. dr. H.W. Bruinse, beste Hein. Ik bewonder je onder andere voor je
onafhankelijke oordeel en je humor. Ik waardeer het zeer dat je lid van de
promotiecommissie wilt zijn.
Prof. dr. C.J.M. Lips, beste Kees. Ik heb je loopbaan al langer kunnen volgen,
doordat wij eens samen in het Westeinde Ziekenhuis hebben gewerkt. Vooral
je integriteit viel mij op. Onze contacten in het AZU naar aanleiding van
gezamenlijke patiºnten waren steeds inspirerend. Ik stel het op hoge prijs dat
je lid wilt zijn van de promotiecommissie.
Prof. dr. B.C.J.M. Fauser, beste Bart. Ik heb je vooral leren kennen als mede-
auteur van enkele artikelen. Ik bewonder je wetenschappelijke inzicht en je
kreativiteit. Ik verheug me op een langdurige samenwerking met jou en je
afdeling. Ik prijs me gelukkig dat je in de promotiecommissie wilde plaatsnemen.
De vele patiºnten dank ik voor hun inspanningen bij het ondergaan van de
uitgebreide cyclusanalyse.
Dr. G.J. Scheffer, beste Gabriºlle. De nauwkeurigheid waarmee jij de vele
gegevens hebt verzameld van de vrijwilligsters, is onovertroffen. Dankzij jou
vele werk kreeg ik vergelijkingsmateriaal voor de patiºntengegevens en kon
ik cycli uit verschillende leeftijdsgroepen vergelijken. Via jou wil ik ook alle
vrijwilligsters danken voor hun inspanningen.
Prof. dr. J.D.F. Habbema, beste Dik. Je adviezen waren steeds verhelderend.
J i j  hebt het vermogen ingewikkelde zaken eenvoudig te laten l i jken.
Ir. C.W.N. Looman, beste Caspar. Onze discussies over het bewerken van de
getallen waren altijd boeiend en diepgaand. Ik stel je gezelschap en je mede-
auteurschap erg op prijs.
Prof. dr. F.H. de Jong, beste Frank. Dank voor de bepalingen van het inhibine
en voor je opbouwende inbreng in Hoofdstuk 7.
De secretaressen, met name Ingrid Donner. Beste Ingrid, dank voor je
voortdurende belangstelling, en dat je altijd klaar staat voor een spoedklus. En
voor het ti jpewerk in de ti jd dat dokters nog geen computer hadden.
De echografisten: dank voor het meten van talloze follikels, en voor jullie
gezelschap.
Alle medewerkers en medewerksters van de polikliniek (wat heerlijk dat jullie
altijd zo opgewekt zijn!), de IVF afdeling en het Fertiliteits- en IVF laboratorium:
i k  d a n k  j u l l i e  v o o r  d e  v o o r t d u r e n d e  b l i j k e n  v a n  b e l a n g s t e l l i n g .
De IVF artsen en embryologen. Jullie waren niet direct betrokken bij mijn
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onderzoek, maar altijd belangstellend en bereid tot het geven van advies.
Prof. dr. N. Masurel, beste Nic. Ik moest mijn diploma van de middelbare
school nog behalen, toen ik op je laboratorium voor Respiratoire Virologie
kwam kijken of het laboratoriumwerk iets voor mij was. Zonder dat daar veel
woorden voor nodig waren, bleken we elkaar te begrijpen. Vooral jouw
bescheidenheid maakte veel indruk op me. Sindsdien heb ik vele weken op
jouw laboratorium doorgebracht, in Leiden en later in Rotterdam. Jouw
toewijding vanuit het laboratorium voor de patiºnten, overtuigde mij ervan
dat in de geneeskunde  ook mijn toekomst lag. Hoewel ik uiteindelijk koos
voor de directe patiºntenzorg, is mijn liefde voor het laboratoriumwerk en het
wetenschappelijk onderzoek gebleven.
Prof. Dr. J. Schoemaker, beste Joop. Toen ik de kans kreeg mij op jouw
afdeling verder te bekwamen in de voortplantingsgeneeskunde, greep ik deze
met beide handen aan.  Van jouw kennis en jouw manier van logisch redeneren
heb ik veel geleerd. Ik heb ook genoten van je humor. De vijfde stelling van
je proefschrift heeft overigens naar mijn mening nog niets van zijn waarde
verloren.
Drs. M.E. Boer-Meisel, beste Margit. De vele uren samen met jou aan de
operatiemicroscoop waren voor mij niet alleen bijzonder leerzaam, maar ook
een groot genoegen. Ook jouw nuchterheid was een voorbeeld voor mij.
Dr. P.G.M. Hompes, beste Peter. Jouw praktische aanpak was altijd verfrissend.
Prof. dr. J. Janssens en prof. dr. N.F.Th. Arts hebben zich erg ingespannen
voor mijn loopbaan na de VU. Beste Jannes, ik weet niet of mijn dank je nog
kan bere iken.  Beste  Nico,  har te l i jk  dank voor  je  kreat ieve  aanpak.
Prof. dr. A.A. Haspels, beste Ary. Jij hebt me steeds het gevoel gegeven dat ik
zeer welkom was in Utrecht. Dit geldt ook voor je opvolgers als hoofd van de
DONG, prof. dr. G.H.A. Visser en prof. dr. A.P.M. Heintz. Beste Gerard en
Peter, ook jull ie bedankt voor het vertrouwen en jull ie voortdurende
belangstelling.
Mijn overige mede-stafleden van de FENDO: dr. J. Koudstaal, drs. M. Kortman,
dr. M. van der Meer. Beste Jan, aan de tijd dat je nog volledig bij ons hoorde
heb ik de beste herinneringen. Je bent niet alleen een geweldige collega, maar
ik heb ook veel van je geleerd, niet in het minst op het gebied van het onderwijs.
Marian en Maartje, jullie collegialiteit is zo groot dat ik lang niet altijd heb
gemerkt hoeveel werk jullie voor mij hebben opgeknapt.
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De studenten d ie  ik  mocht  bege le iden b i j  hun doctoraa lscr ipt ie  of
wetenschappelijke stage hebben mij erg geholpen met literatuuronderzoek en
het invoeren van patiºntengegevens. Beste Tamer Tadros, Jippe Balt, Susan
van Bommel en Maisa Sjak Shie: dank ook voor de leerzame discussies.
Drs. G.P.J. Alsbach, beste Hans. Jouw vriendschap is voor mij steeds heel
waardevol  gewees t .  A ls  ik  met  een  onoplosbaar  prob leem za t  met
dataverwerking, zocht ik jou op. Tot mijn verrassing had je dan altijd de
oplossing bij de hand.
Prof. dr. J.H.H. Thijssen, beste Jos. Vanaf onze kennismaking toonde jij je
interesse voor mijn persoon en mijn vorderingen op wetenschappelijk gebied.
Ook kon ik altijd voor advies bij je terecht. Dat heeft me altijd een vertrouwd
gevoel gegeven.
Mijn broers en zuster hebben steeds hun belangstelling voor de vorderingen
van dit proefschrift laten blijken. Jan, Hans, Elly, Henk, Albert en ook verdere
familie: dank hiervoor.
Onze kinderen Floris, Fleur, Mirit en Jasmijn: fantastische lieverds, jullie
voortdurende be langste l l ing  en more le  Øn daadwerke l i jke  hulp  z i jn
hartverwarmend. Ik hoop maar dat ik heel oud word om van jullie te kunnen
blijven genieten.
Liefste Marie-Anne. De voor- en achterkant van het boekje zijn onmiskenbaar
jouw werk. Maar ik weet als geen ander dat je bijdrage aan alles wat daar
tussen zit oneindig veel groter is. Voor mij is met dit boekje een droom
uitgekomen. Ik hoop dat ik jou net zo kan helpen om jouw dromen te laten
uitkomen.
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CURRICULUM VITAE
Pieter van Zonneveld werd op 14 februari 1948 geboren in de goede stad
Leiden. Hij behaalde in 1966 met lof het diploma HBS-B aan het Rembrandt-
Lyceum. In het laatste schooljaar kwam hij in contact met de arts-viroloog dr.
N. Masurel, hoofd van het Laboratorium voor Respiratoire Virologie van het
Academisch Ziekenhuis Leiden (later hoogleraar aan de Erasmus Universiteit
te Rotterdam). Door diens voorbeeld koos Pieter voor de studie geneeskunde.
Hij studeerde aan de Rijksuniversiteit Leiden, waar hij op 29 oktober 1971 zijn
doctoraaldiploma en op 18 januari 1974 zijn artsenbul kreeg uitgereikt. In de
academische vakanties werkte hij aan diverse projecten mee op het Virologisch
Laboratorium te Leiden, later ook te Rotterdam. Met de artsenbul in de hand
koos hij, ondanks zijn liefde voor de Medische Microbiologie, voor een loopbaan
in de directe patiºntenzorg. Na een jaar als algemeen assistent in het St.
Barbaraziekenhuis te Geleen werkte hij, enthousiast geworden voor de
Verloskunde en Gynaecologie, nog een jaar in dit ziekenhuis onder leiding
van de gynaecologen dr. C.W.J. Belder en J.A. Zandvoort. De specialisatie tot
gynaecoloog werd gestart op 1 mei 1976 in het Westeinde Ziekenhuis te s-
Gravenhage. Hij werd opgeleid door dr. J.C. Seelen (A-opleider) en mevr. J.C.
Been (chef de clinique). In deze periode trad hij in het huwelijk met Marie-
Anne Neecke. Vanaf 1 mei 1980 ontving hij zijn B-opleiding in het Bronovo-
Nebo Ziekenhuis te s-Gravenhage, met als begeleiders dr. N.D. Bessem (B-
opleider), P.H. Kolkman en M.R. Mackenzie. In dit jaar werd zoon Floris in het
Bronovo  Z iekenhu i s  geboren .  Op 1  me i  1981  werd  P i e t e r  in  he t
specialistenregister ingeschreven. Gedurende de vier volgende jaren nam hij
waar in diverse perifere praktijken Verloskunde en Gynaecologie. Onder andere
zette hij voor langere tijd de praktijk voort van W.F. Ho Kang You in het
Horacio E. Oduber Hospitaal te Oranjestad, Aruba, Nederlandse Antillen. Om
meer ervaring op te doen in de Gynaecologische Oncologie werkte hij ook
enige tijd in het Antoni van Leeuwenhoek Ziekenhuis te Amsterdam, onder
leiding van E.J. Aartsen en dr. J.V.T.H. Hamerlynck. De periode november
1981  januari 1982 bekwaamde hij zich in de Gynaecologische Microchirurgie
op de afdeling van prof. dr. I.A. Brosens aan het Academisch Ziekenhuis St.
Raphaºl te Leuven, onder leiding van prof. dr. W. Boeckx, prof. dr. S. Gordts
en mevr. Lieve van den Maegdenburgh-Desmet. Tijdens deze stage werd in
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het St. Raphaºl Ziekenhuis dochter Fleur geboren. Tijdens de verdere periode
van waarnemen volgde de geboorte van dochter Mirit, in het Bronovo
Ziekenhuis te s-Gravenhage. Op 1 mei 1985 begon Pieter van Zonneveld als
 f e l l ow   op  de  a fde l i ng  Voor tp l an t i ng s endoc r ino log i e  en
Vruchtbaarheidsonderzoek (VEVO) van het Academisch Ziekenhuis Vrije
Universiteit te Amsterdam. Hier werd hij verder opgeleid in het subspecialisme
Fertiliteit, onder leiding van prof. dr. J. Schoemaker, mevr. M.E. Boer-Meisel
(tubachirurg) en dr. P.G.M. Hompes (chef de policlinique). Ook in het VU
ziekenhuis, werd dochter Jasmijn geboren. Op 1 mei 1987 maakte Pieter de
overstap naar het Universitair Medisch Centrum Utrecht, waar hij sindsdien
staflid is op de afdeling Fertiliteit en Voortplantingsendocrinologie (FENDO).
